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SCIENTIFIC OPINION 
Scientific Opinion on Dietary Reference Values for zinc
1
 
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA)
2, 3
 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Following a request from the European Commission, the Panel on Dietetic Products, Nutrition and Allergies 
(NDA) derived Dietary Reference Values for zinc, using a two-stage factorial approach and reference values for 
body weight. The first stage of estimating physiological requirements used studies that had physiologically 
plausible data, specifically related to faecal excretion of endogenous zinc. Adult physiological requirements were 
closely related to body size, and sex differences were not detectable after adjustment for body weight. Average 
Requirements (ARs) for dietary zinc necessary to meet physiological requirements were estimated using 
saturation response modelling, taking into account the inhibitory effect of dietary phytate on zinc absorption. 
Estimated ARs and Population Reference Intakes (PRIs) are provided for phytate intake levels of 300, 600, 900 
and 1 200 mg/day, which cover the range of mean/median intakes observed in European populations. ARs range 
from 6.2 to 10.2 mg/day for women with a reference weight of 58.5 kg and from 7.5 to 12.7 mg/day for men 
with a reference weight of 68.1 kg. PRIs were derived from the zinc requirement of individuals with a body 
weight at the 97.5
th
 percentile for reference weights for men and women and range from 7.5 to 12.7 mg/day for 
women and from 9.4 to 16.3 mg/day for men. ARs for infants from seven months of age and for children were 
estimated factorially, based on extrapolation from estimates of adult losses plus zinc needs for growth, and range 
from 2.4 to 11.8 mg/day. PRIs for infants and children were derived by assuming a coefficient of variation of 
10 %, and range from 2.9 to 14.2 mg/day. For pregnancy and lactation, additional zinc requirements related to 
fetal and maternal tissues and transfer of zinc into breast milk, respectively, were considered and additional PRIs 
of 1.6 and 2.9 mg/day, respectively, were estimated. 
© European Food Safety Authority, 2014 
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SUMMARY 
Following a request from the European Commission, the EFSA Panel on Dietetic Products, Nutrition 
and Allergies (NDA) was asked to deliver a scientific opinion on Dietary Reference Values (DRVs) 
for the European population, including zinc. 
Zinc has a wide array of vital physiological functions. It has a catalytic role in each of the six classes 
of enzymes. The human transcriptome has 2 500 zinc finger proteins, which have a broad intracellular 
distribution and the activities of which include binding of RNA molecules and involvement in protein–
protein interactions. Thus, their biological roles include transcriptional and translational 
control/modulation and signal transduction. 
The majority of dietary zinc is absorbed in the upper small intestine. The luminal contents of the 
duodenum and jejunum, notably phytate, can have a major impact on the percentage of zinc that is 
available for absorption. Absorption of zinc by the enterocyte is regulated in response to the quantity 
of bioavailable zinc ingested. Albumin is the major transporter of zinc in both portal and systemic 
circulation. Virtually no zinc circulates in a free ionised form, and the majority of total body zinc is in 
muscle and bone; zinc does not have an identified major storage site. The quantity of zinc secreted into 
and excreted from the intestinal tract depends on body zinc concentrations, and the quantities of 
endogenous zinc in the faeces and exogenous zinc absorbed in normal adults are related. The kidneys 
and integument are minor routes of loss of endogenous zinc. 
Plasma/serum zinc concentration and other putative biomarkers of zinc adequacy, deficiency and 
excess are not useful for estimating DRVs for zinc. Zinc requirements have been estimated by the 
factorial approach involving two stages. The first is the estimation of physiological requirements, 
defined as the minimum quantity of absorbed zinc needed to match losses of endogenous zinc and to 
meet any additional requirements for absorbed zinc that may be necessary for growth in healthy well-
nourished infants and children, and in pregnancy and lactation. The second stage is the determination 
of the quantity of dietary zinc available for absorption that is needed to meet these physiological 
requirements. From the published literature, 15 studies were identified that included data on 
endogenous faecal zinc and total absorbed zinc that enabled an estimation to be made of the 
physiological zinc requirements of adults. Individual’s data from these studies were supplied by the 
authors. Data were assessed for physiological plausibility and, after careful evaluation, some data were 
excluded from further calculations. The final numbers of subjects contributing data to the estimate of 
physiological zinc requirements were 31 males and 54 females, from a total of 10 studies. Dietary 
phytate intakes were available for some of the included studies, either as mean study values or as 
individual’s data. The range of dietary phytate intakes in the available data was 0–2 080 mg/day. 
Multiple regression analysis was used to evaluate the possible relationships between physiological 
requirements and sex, zinc balance (difference between absorbed zinc and total losses of endogenous 
zinc) and body size. The coefficient of determination (R2) values for the models with body weight, 
height, body mass index and body surface area variables were 0.46, 0.42, 0.37 and 0.47, respectively. 
It was decided to use the equation relating physiological requirement to body weight in further 
analyses, for reasons of convenience and accuracy of measurement. The equation for physiological 
requirement was calculated on the basis that physiological requirement is equivalent to total absorbed 
zinc when absorbed zinc minus total endogenous zinc losses equals zero at a given body weight. For 
deriving the dietary zinc requirement, a trivariate saturation response model of the relationship 
between zinc absorption, and dietary zinc and phytate was established using 72 mean datasets 
(reflecting 650 individual measurements) reported in 18 publications. The R2 of the fit of this model 
was 0.81. From this model, the Average Requirement (AR) was determined as the intercept of the total 
absorbed zinc needed to meet physiological requirements. Estimated ARs and Population Reference 
Intakes (PRIs) for zinc are provided for phytate intake levels of 300, 600, 900 and 1 200 mg/day, 
which cover the range of mean/median phytate intakes observed in European populations. ARs range 
from 6.2 to 10.2 mg/day for women with a reference body weight of 58.5 kg and from 7.5 to 
12.7 mg/day for men with a reference body weight of 68.1 kg. PRIs for adults were estimated as the 
zinc requirement of individuals with a body weight at the 97.5th percentile for reference body weights 
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for men and women, respectively, and range from 7.5 to 12.7 mg/day for women and from 9.4 to 
16.3 mg/day for men. 
For infants from seven months of age and children, DRVs for zinc were derived using the factorial 
approach, taking into account endogenous zinc losses via urine, sweat and integument, faeces and, in 
adolescent boys and girls, semen and menses, respectively, as well as zinc required for synthesis of 
new tissue for growth. Urinary and integumental losses were extrapolated based on estimates of adult 
losses, whereas endogenous faecal zinc losses were estimated by linear regression analysis of 
endogenous faecal zinc losses versus body weight for the subjects contributing data to the adult 
estimates, and for infants and young children from two studies from China and the USA. Zinc 
requirements for growth were taken into account based on the zinc content of new tissue, and by 
estimating daily weight gains for each age group. Absorption efficiency of zinc from mixed diets was 
assumed to be 30 %. Estimated ARs range from 2.4 mg/day in infants aged 7–11 months to 
11.8 mg/day in adolescent boys. Owing to the absence of reference body weights for infants and 
children at the 97.5th percentile, and in the absence of knowledge about the variation in requirements, 
PRIs for infants and children were estimated based on a coefficient of variation (CV) of 10 %, and 
range from 2.9 to 14.2 mg/day. 
The physiological requirements for pregnancy and lactation can be calculated by adding the increases 
in physiological requirements that are predicted to meet the demands for new tissue primarily of the 
conceptus, and the replacement of zinc that is secreted in breast milk. For pregnancy, an additional 
requirement for zinc for the four quarters of pregnancy of about 0.4 mg/day was assumed because of 
zinc accumulation in the fetus; placental, uterine and mammary tissue; amniotic fluid and maternal 
blood. The Panel decided not to use the trivariate model to estimate the dietary zinc intake required to 
meet the additional physiological requirement. Instead, the Panel applied a mean fractional absorption 
of zinc of 0.3 that has been observed in healthy adults to the physiological requirement of 0.4 mg/day. 
The additional requirement for pregnant women was calculated to be 1.3 mg/day and the additional 
PRI for pregnancy was estimated based on a CV of 10 % and was 1.6 mg/day. 
For lactation, taking into account breast milk zinc concentration, the breast milk volume transferred 
and the postnatal redistribution of zinc owing to involution of the uterus and reduction of maternal 
blood volume, the additional physiological requirement calculated over six months of lactation was 
estimated to be 1.1 mg/day. Assuming that fractional absorption of zinc is increased 1.5-fold in 
lactation, and applying a fractional absorption of zinc of 0.45 to the additional physiological 
requirement of 1.1 mg/day, resulted in an additional dietary requirement for lactating women of 
2.4 mg/day. The additional PRI for lactation, based on a CV of 10 %, was 2.9 mg/day. 
Meat, legumes, eggs, fish, and grains and grain-based products are rich dietary zinc sources. On the 
basis of data from 12 dietary surveys in nine European Union (EU) countries, zinc intake was assessed 
using food consumption data from the EFSA Comprehensive Food Consumption Database and zinc 
composition data from the EFSA nutrient composition database. Average zinc intake ranged from 4.6 
to 6.2 mg/day in children aged one to less than three years, from 5.5 to 9.3 mg/day in children aged 3 
to < 10 years, from 6.8 to 14.5 mg/day in adolescents (10 to < 18 years) and from 8.0 and 14.0 mg/day 
in adults. The main food groups contributing to zinc intake were meat and meat products, grains and 
grain-based products, and milk and dairy products. Published data on phytate intake in the EU are 
limited and indicate a wide range of dietary phytate intakes. 
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION 
Scientific advice on nutrient intakes is important as the basis of Community action in the field of 
nutrition, for example such advice has in the past been used as the basis of nutrition labelling. The 
Scientific Committee for Food (SCF) report on nutrient and energy intakes for the European 
Community dates from 1993. There is a need to review and if necessary to update these earlier 
recommendations to ensure that the Community action in the area of nutrition is underpinned by the 
latest scientific advice. 
In 1993, the SCF adopted an opinion on nutrient and energy intakes for the European Community.4 
The report provided Reference Intakes for energy, certain macronutrients and micronutrients, but it did 
not include certain substances of physiological importance, for example dietary fibre. 
Since then, new scientific data have become available for some of the nutrients, and scientific advisory 
bodies in many European Union Member States and in the United States have reported on 
recommended dietary intakes. For a number of nutrients these newly established (national) 
recommendations differ from the reference intakes in the SCF (1993) report. Although there is 
considerable consensus between these newly derived (national) recommendations, differing opinions 
remain on some of the recommendations. Therefore, there is a need to review the existing EU 
Reference Intakes in the light of new scientific evidence, and taking into account the more recently 
reported national recommendations. There is also a need to include dietary components that were not 
covered in the SCF opinion of 1993, such as dietary fibre, and to consider whether it might be 
appropriate to establish reference intakes for other (essential) substances with a physiological effect. 
In this context, EFSA is requested to consider the existing Population Reference Intakes for energy, 
micro- and macronutrients and certain other dietary components, to review and complete the SCF 
recommendations, in the light of new evidence, and in addition advise on a Population Reference 
Intake for dietary fibre. 
For communication of nutrition and healthy eating messages to the public it is generally more 
appropriate to express recommendations for the intake of individual nutrients or substances in food-
based terms. In this context, EFSA is asked to provide assistance on the translation of nutrient based 
recommendations for a healthy diet into food based recommendations intended for the population as a 
whole. 
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION 
In accordance with Article 29 (1)(a) and Article 31 of Regulation (EC) No. 178/2002,5 the 
Commission requests EFSA to review the existing advice of the Scientific Committee for Food on 
population reference intakes for energy, nutrients and other substances with a nutritional or 
physiological effect in the context of a balanced diet which, when part of an overall healthy lifestyle, 
contribute to good health through optimal nutrition. 
In the first instance, EFSA is asked to provide advice on energy, macronutrients and dietary fibre. 
Specifically, advice is requested on the following dietary components: 
• Carbohydrates, including sugars; 
• Fats, including saturated fatty acids, polyunsaturated fatty acids and monounsaturated fatty 
acids, trans fatty acids; 
                                                     
4 Scientific Committee for Food. Nutrient and energy intakes for the European Community. Reports of the Scientific 
Committee for Food, 31st series. Office for Official Publication of the European Communities, Luxembourg, 1993. 
5 Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general 
principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in 
matters of food safety. OJ L 31, 1.2.2002, p. 1–24. 
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• Protein; 
• Dietary fibre. 
Following on from the first part of the task, EFSA is asked to advise on population reference intakes 
of micronutrients in the diet and, if considered appropriate, other essential substances with a 
nutritional or physiological effect in the context of a balanced diet which, when part of an overall 
healthy lifestyle, contribute to good health through optimal nutrition. 
Finally, EFSA is asked to provide guidance on the translation of nutrient based dietary advice into 
guidance, intended for the European population as a whole, on the contribution of different foods or 
categories of foods to an overall diet that would help to maintain good health through optimal nutrition 
(food-based dietary guidelines). 
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ASSESSMENT 
1. Introduction 
In 1993, the Scientific Committee for Food (SCF) published an opinion on nutrient and energy intakes 
for the European Community (SCF, 1993). For zinc (Zn), Population Reference Intakes (PRIs) were 
proposed for all population groups from seven months of age onwards, based on zinc requirements to 
replace basal losses and losses via breast milk in lactating women, or an increment to supply zinc for 
growth in children and pregnant women. In addition, a Lowest Threshold Intake was derived for men 
and women (see Section 4). 
2. Definition/category 
2.1. Chemistry 
Zinc has an atomic mass of 65.39 Da and is the 24th most abundant element in the Earth’s crust. It 
exists as a stable divalent cation. Considered to be of fundamental importance to the far-ranging 
biology of zinc is its ability for fast exchange coupled with strong binding to organic molecules, 
especially to thiolate and amine electron donors. Zinc does not exhibit direct redox activity, a feature 
which facilitates its safe transport within the body (Krezel et al., 2007). There are five naturally 
occurring stable isotopes of zinc; the most abundant is 64Zn (48.63 % natural abundance). 
2.2. Functions of zinc 
2.2.1. Biochemical functions 
Zinc has a wide array of vital physiological functions and is ubiquitous within every cell in the body. 
It is this very abundance that is thought to be the reason why it has proved so challenging to link zinc 
deficiency with specific phenotypic features. However, three general functional classes (catalytic, 
structural and regulatory) define zinc’s role in biology (King and Cousins, 2014). Zinc has a structural 
or catalytic role, or both, in each of the six classes of enzymes, although unequivocal evidence of a 
direct link between signs of zinc deficiency and a deficiency of a specific metallo-enzyme has not yet 
been confirmed in humans. 
The structural role of zinc is exemplified by transcription factors having zinc motifs (zinc fingers) 
which link with cysteine and histidine to form a tetrahedral Zn2+ coordination complex. The presence 
of zinc is necessary for the activity of these zinc fingers. The human transcriptome has 2 500 zinc 
finger proteins, which represent 8 % of the genome and account for a significant portion of the zinc 
requirement (King and Cousins, 2014). Zinc fingers have a range of binding affinities, suggesting that 
some zinc finger-dependent transcription may be especially vulnerable to low zinc absorption. Zinc 
finger proteins have a broad intracellular distribution and their activities include binding of RNA 
molecules and involvement in protein–protein interactions. Thus, their biological roles include 
transcriptional and translational control/modulation and signal transduction. A combination of 
structural and regulatory functions are involved in the large quantities of zinc movement involved in 
the release of insulin, the secretion of zinc-containing digestive enzymes and acid secretion by parietal 
cells in the stomach (Guo et al., 2010). 
Regulation of gene expression is a key biochemical role of zinc. The metal-response element (MRE)-
binding transcription factor (MTF1) is thought to provide zinc responsiveness to many genes (King 
and Cousins, 2014), including a master regulatory role for micro RNA genes involved in gene 
expression. 
A second regulatory role of zinc is as a regulator of intracellular signalling, analogous to calcium but 
at a finer level of control, in particular through the regulation of kinase and phosphorylase activity 
(King and Cousins, 2014). The control of phosphorylation/dephosphorylation may explain the effects 
of zinc on phosphorylated transcription factors, the effects of zinc on cell surface receptor binding of 
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growth factors and cytokine receptors, and the major effects of zinc on virtually all aspects of the 
immune system. 
2.2.2. Health consequences of deficiency and excess 
2.2.2.1. Deficiency 
There is a lack of specific health effects of zinc deficiency, apart from those observed in infants with 
acrodermatitis enteropathica (see below), and this is the consequence of its essentiality for many core 
biochemical processes. There is protection by homeostatic mechanisms at both a whole body and a 
tissue level, which, during periods of rapid growth, include slowing of linear growth (i.e. bone 
growth). Although by no means unique to zinc deficiency, slowing of linear growth is one of the most 
clearly defined effects of chronic zinc deficiency. The particular vulnerability of the immune system to 
zinc deficiency results in part from its high rate of cell proliferation. However, the immune system 
also epitomises the dependence of many cellular biochemical processes on zinc. These may include 
atypical regulation of cytokine gene expression and signalling pathways, which can disrupt the balance 
of cell-mediated versus humoral immunity. The failure of zinc-dependent structural factors needed for 
antigen presentation may enhance the risk of microbial and parasitic infections (King and Cousins, 
2014), of which enteric infections have been the principal foci of interest (Black, 2003). 
Acute severe zinc deficiency results from genetic defects in zinc transporters involved in the intestinal 
absorption of zinc and in the transfer of zinc by the mammary gland into human milk, collectively 
termed acrodermatitis enteropathica. The onset of clinical features after birth is rapid. The most 
superficially apparent are skin lesions, which are, characteristically, most prominent around the body 
orifices and on the extremities. Diarrhoea is prominent in most but not all cases. Growth failure is 
progressive and these infants are susceptible to a range of immune defects and infections. Loss of 
appetite and of taste perception are notable, and alterations in affect and mood are early phenomena of 
incipient zinc deficiency in children with acrodermatitis enteropathica when their supplemental zinc 
becomes inadequate. Response to treatment with zinc is profound, but without treatment there is 
typically a fatal outcome in acrodermatitis enteropathica by later infancy. Similar acute acquired zinc 
deficiency states have been extensively documented, primarily in patients dependent on intravenous 
nutrition lacking zinc (Younoszai, 1983). 
2.2.2.2. Excess 
Chronic high zinc intake can result in severe neurological diseases attributable to copper deficiency 
(Hedera et al., 2009). The SCF (2002) has set a Tolerable Upper Intake Level (UL) of 25 mg/day for 
adults, including pregnant and lactating women, based on studies of zinc supplementation for up to 14 
weeks. A No Observed Adverse Effect Level of 50 mg/day was based on the absence of any adverse 
effect on a wide range of relevant indicators of copper status in controlled metabolic studies. An 
Uncertainty Factor of 2 was applied. The UL for children was extrapolated from the UL for adults 
using body weight to the power of 0.75 and reference body weights for European children (SCF, 
1993). 
2.3. Physiology and metabolism 
Zinc transporter gene regulation currently dominates all aspects of cellular zinc metabolism. The ZnT 
family (SLC30a) facilitates the efflux of zinc across cell membranes and into vesicles. The ZIP 
transporters do the reverse. Up- or down-regulation of these genes in response to zinc intake 
contributes to the tight homeostatic control of zinc by the small intestine. Diet is among the factors 
that regulate transporter gene expression. These same families of transporters have the major role of 
regulating uptake, excretion and metabolism of zinc by all cells in the body. Metallothionein also has a 
supportive role in zinc metabolism. Polymorphisms in these genes can affect phenotypic expression. 
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2.3.1. Intestinal absorption 
Small quantities of zinc may be absorbed throughout the entire gastro-intestinal tract, but the majority 
is absorbed in the upper small intestine. When ingested from food, it will be firmly bound, particularly 
to protein thiols and nitrogen ligands. The phytate–zinc ligand is weakened at low pH (Cheryan, 1980) 
and the results of stable isotope studies of zinc absorption are consistent with the zinc being released 
from these ligands and entering a common pool in the acidic environment of the stomach and, 
subsequently, being bound to a variety of other organic ligands, including phytate in the alkaline 
medium of the distal duodenum. The form in which bioavailable zinc is presented to the apical surface 
of the enterocyte and the zinc transporters, particularly Zip 4, has not been fully elucidated. The 
luminal contents of the duodenum and jejunum in particular, especially phytate, can have a major 
impact on the percentage of zinc available for absorption. With diets low in phytate and low in zinc, 
for example less than 4 mg/day, the fraction of zinc absorbed may be as high as 60 % or more. The 
fraction of absorbed zinc then decreases progressively with increasing dietary zinc (Hambidge et al., 
2005). The uptake of zinc and its transfer into the body by the enterocyte is regulated in response to 
the quantity of bioavailable zinc ingested (Chung et al., 2008); this relationship between the quantity 
of zinc absorbed and that ingested is best fit with saturation response modelling (Hambidge et al., 
2010). 
WHO/FAO (2004) categorised diets with regard to the fact that their impact on zinc absorption is 
mainly influenced by the phytate–zinc molar ratio and the amount and source of dietary protein. In 
most European countries, the main contributors to dietary protein intake of adults are meat and meat 
products, followed by grains and grain-based products, and milk and dairy products. The mean protein 
intake of European adults is generally above the Average Requirement (AR) (EFSA NDA Panel, 
2012). Thus, for the majority of the European population that consumes mixed diets, the Panel 
considers that the phytate content of the diet has a more profound effect on zinc availability than the 
protein content, and that at zinc intake adequate to meet the requirement the absorption efficiency of 
zinc from the diet is moderate or high (Table 1). 
Table 1:  Criteria for categorising diets according to their potential absorption efficiency of zinc 
(adapted from WHO/FAO (2004)) 
Absorption efficiency Principal dietary characteristics 
High Refined diets low in cereal fibre, low in phytic acid content and with a phytate–zinc 
molar ratio below 5; adequate protein content principally from non-vegetable sources, 
such as meat and fish. At a zinc intake of 10 mg/day, a phytate–zinc molar ratio of 
below 5 is equivalent to a phytate intake of below about 500 mg/day 
Moderate Mixed diets containing animal or fish protein 
(Lacto-)ovo-vegetarian or vegan diets not based primarily on unrefined cereal grains or 
high-extraction-rate flours 
A phytate–zinc molar ratio of total diet within the range 5–15, or not exceeding 10 if 
more than 50 % of the energy intake is accounted for by unfermented, unrefined cereal 
grains and flours 
At a zinc intake of 10 mg/day, a phytate–zinc molar ratio of 5–15 is equivalent to a 
phytate intake of about 500–1 500 mg/day 
Low Diets high in unrefined, unfermented and ungerminated cereal grain (a), especially when 
intake of animal protein is negligible 
Phytate–zinc molar ratio of total diet exceeds 15; high-phytate soya-protein products 
constitute the primary protein source 
Diets in which, singly or collectively, approximately 50 % of the energy intake is 
accounted for by the following high-phytate foods: high-extraction-rate (≥ 90 %) 
wheat, rice, maize, grains and flours, oatmeal, and millet; sorghum, cowpeas, pigeon 
peas, grams, kidney beans, black-eyed beans and groundnut flours 
At a zinc intake of 10 mg/day, a phytate–zinc molar ratio exceeding 15 is equivalent to 
a phytate intake higher than about 1 500 mg/day 
(a): Germination of cereal grains or fermentation (e.g. leavening) of many flours can reduce antagonistic potency of 
phytates; if done, the diet should then be classified as having a moderate absorption efficiency of zinc. 
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2.3.2. Transport in blood 
Albumin is the major transporter of zinc in both portal and systemic circulation. Virtually no zinc 
circulates unbound. Zinc in the plasma compartment is turned over more than 130 times per day and 
80 % of circulating zinc is in the cellular components of the blood. 
2.3.3. Distribution to tissues 
Total body zinc in adult males is approximately 2.5 g in men and 1.5 g in women. The majority of 
total body zinc, i.e. about 85 %, is in muscle and bone. There are metabolic pools with both short- and 
long-term turnover. The exchangeable zinc pool exchanges with plasma zinc in approximately two 
days and is thought to represent the most metabolically active portion of total body zinc. 
Zinc uptake capacity by the human placenta is inversely related to maternal plasma zinc 
concentrations and increases with increasing gestational age. There are no recent data on the 
metabolism of zinc by the placenta and fetus at the molecular level. 
2.3.4. Storage 
Zinc does not have an identified major storage site. The liver provides a limited short-term store of 
zinc, which is readily released as needed. Twenty per cent of bone zinc, which accounts for about 
30 % of total body zinc, has been reported to be released into the circulation in times of depletion at a 
slower rate than liver zinc. At times of increased bone turnover and tissue catabolism, zinc is released 
adventitiously from these depots. Although muscle has the largest quantity of zinc, release of this zinc 
in response to zinc depletion has not been documented. Within all cells, vesicles provide sites for 
temporary storage. 
2.3.5. Metabolism 
The rapid turnover of plasma zinc reflects its exchange with all tissues and organs in the body. There 
is a rapidly exchanging pool of zinc that fully exchanges with zinc in plasma and accounts for about 
10 % of total body zinc. This zinc is found in soft tissues other than muscle, particularly in the liver 
(Wastney et al., 1986; Miller et al., 2000). 
2.3.6. Elimination 
2.3.6.1. Faeces 
The quantity of zinc secreted into and excreted from the gastro-intestinal tract depends on zinc intake 
and status. The amount of endogenous zinc in the faeces and the quantity of exogenous zinc absorbed 
in normal adults is positively related. 
2.3.6.2. Urine and sweat 
The kidneys and integument are relatively minor routes of excretion of endogenous zinc. There is a 
weak positive relationship between absorbed zinc and urinary zinc. However, the latter declines 
markedly when dietary zinc is severely reduced. For subjects with a normal zinc status, urinary zinc 
losses of 0.5 mg/day for men and 0.3 mg/day for women have been calculated based on individual 
data from studies by Jackson et al. (1984); Turnlund et al. (1984); Lowe et al. (1997); Miller et al. 
(2000); King et al. (2001); Pinna et al. (2001); Sheng et al. (2009) (see Section 5.1.1). Studies of 
whole body surface zinc losses in men have indicated combined integumental and sweat zinc losses of 
0.5 mg/day for men (Jacob et al., 1981; Milne et al., 1983; Johnson et al., 1993). 
2.3.6.3. Breast milk 
During lactation, the quantity of zinc transferred from the mammary gland to the exclusively (or 
partially) breast-fed infant decreases, and this physiological decline is quite notable. Milk zinc 
concentrations do not appear to be associated with maternal zinc status or dietary zinc intake (Mills, 
1989), and long-term ingestion of supplementary zinc (15 mg/day from two weeks post partum until 
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seven months) did not affect the rate of decline of milk zinc concentration in supplemented women 
(Krebs et al., 1995). A comprehensive review of breast milk zinc concentrations and zinc transferred 
from mother to child covered 63 studies globally, including 12 studies from European countries 
(Brown et al., 2009). Zinc concentrations (mean ± SD) were 4.11 ± 1.50 mg/L below one month 
(n = 74 observations), 1.91 ± 0.53 mg/L at one to two months (n = 42), 0.98 ± 0.35 mg/L at three to 
five months (n = 24) and 0.77 ± 0.22 mg/L at 6–11 months post partum (n = 24). Taking into account 
breast milk volume, Brown et al. (2009) estimated a milk zinc transfer of 2.52 mg/day for the first 
month, 1.37 mg/day for months 1 to 2 and 0.86 mg/day for months 3 to < 6. 
Additional data on breast milk zinc concentrations in mothers of term infants in Europe are given in 
Appendix A. 
2.3.7. Interaction with other nutrients 
High-dose iron supplements can interfere with zinc absorption when provided simultaneously with 
zinc supplements. There is no interference with zinc absorption from iron added to foods. 
High doses of zinc can interfere with copper absorption (see Section 2.2.2.2). 
2.3.8. Biomarkers 
A systematic review and meta-analysis of the literature examining the efficacy of potential biomarkers 
of zinc status was undertaken by Lowe et al. (2009). This review presented an analysis of data from 
more than 32 potential biomarkers; however, for many biomarkers, there was insufficient evidence to 
assess their reliability. 
2.3.9. Plasma zinc concentration 
In apparently healthy subjects, plasma and serum zinc concentration is affected by intake, both 
inadequate and excessive. Lowe et al. (2009) concluded that plasma zinc concentration responds to an 
increase in intake over short periods, but that the homeostatic mechanisms that act to maintain plasma 
zinc concentration within the physiological range may prevent high plasma concentrations from being 
sustained over a prolonged period. 
Plasma zinc concentrations are reduced in severe inherited and acquired zinc deficiency states 
(Wessells et al., 2014). However, as a biomarker, sensitivity is poor and, with more moderate zinc 
deficiency states, lacks specificity (King, 2011). Plasma zinc concentration has been recommended as 
a biomarker of zinc status and of the population’s risk of zinc deficiency by the World Health 
Organization (WHO), the United Nations Children’s Fund (UNICEF), the International Atomic 
Energy Agency (IAEA) and the International Zinc Nutrition Consultative Group (IZiNCG) (de 
Benoist et al., 2007). 
2.3.10. Hair zinc concentration 
Low hair zinc concentrations have been associated with retarded growth (Gibson et al., 1989; Gibson 
et al., 1991). However, there are potential and actual confounders which may have a role in apparent 
age-related differences in hair zinc concentrations (Hambidge et al., 1972). Based on three randomised 
controlled trials with a zinc intake between 15 and 100 mg/day, Lowe et al. (2009) concluded that hair 
zinc concentration increases in response to an increase in zinc intake, but that the effect of zinc 
depletion is inconclusive. 
2.3.11. Urinary zinc concentration 
Urinary zinc concentration has been found to increase in response to increases in zinc intake resulting 
from zinc supplementation; however, the response to zinc depletion has been reported to be 
inconclusive (Lowe et al., 2009). 
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2.3.12. Other biomarkers 
It was previously hypothesised that there may be biomarkers based on zinc transporters or 
metallothionein. However, this has not been confirmed. Candidates based on proteomic and 
metabolomic techniques are of current research interest (Kettunen et al., 2012; Ryu et al., 2012); 
however, the Panel considers that they are not yet useful for deriving Dietary Reference Values 
(DRVs). 
2.3.13. Conclusion on biomarkers 
The Panel considers that neither plasma/serum zinc concentration nor any other putative biomarker is 
useful for estimating DRVs for zinc. 
2.4. Effects of genotype 
The most well-documented and severe polymorphisms for zinc result in the clinical syndrome of 
acrodermatitis enteropathica (Zip 4) and in the “lethal mouse syndrome (ZT4)”. A similar defect in 
cattle (Adema disease) is less well characterised. There are no known genotypes that would affect the 
estimation of DRVs for zinc. Significant results for altered putative zinc biomarkers in groups of 
people with differing gene variants have been documented by Lowe et al. (2013). 
3. Dietary sources and intake data 
3.1. Dietary sources 
Meat, legumes, eggs, fish, and grains and grain-based products are rich dietary zinc sources. 
Currently, zinc acetate, zinc bisglycinate, zinc chloride, zinc citrate, zinc gluconate, zinc lactate, zinc 
oxide, zinc carbonate and zinc sulphate may be added to both foods6 and food supplements.7 Zinc L-
ascorbate, zinc L-aspartate, zinc L-lysinate, zinc malate, zinc mono-L-methionine sulphate, zinc L-
pidolate and zinc picolinate may be added to food supplements only. The zinc content content of 
infant and follow-on formulae8 and processed cereal-based foods and baby foods for infants and young 
children9 is regulated. 
3.2. Dietary zinc intake 
Dietary intake of zinc was estimated by the Evidence Management Unit (DATA) of EFSA using the 
EFSA Comprehensive Food Consumption Database (EFSA, 2011b) and the EFSA Food Composition 
Database. This assessment includes food consumption data from 12 dietary surveys (Appendix B) 
from nine countries (Finland, France, Germany, Ireland, Italy, Latvia, the Netherlands, Sweden and 
the UK), which were either already classified or re-classified (French and Italian data), in accordance 
with the FoodEx2 food classification system (EFSA, 2011a). The data covered all age groups from 
infants to adults aged 75 years or older. The EFSA Food Composition Database was compiled during 
a procurement project (Roe et al., 2013) involving 14 national food database compiler organisations, 
who were allowed to borrow compatible data from other countries if no original composition data 
were available. This assessment includes food composition information from Finland, France, 
Germany, Italy, the Netherlands, Sweden and the UK. The amount of borrowed zinc values in these 
datasets varied between 14 and 88 %. For Ireland and Latvia, UK and German food composition data 
were used, respectively, because no composition data from these countries were available. Zinc 
concentration was directly available for 2 063 food terms of the food consumption data used in this 
                                                     
6 Regulation (EC) No 1925/2006 of the European Parliament and of the Council of 20 December 2006 on the addition of 
vitamins and minerals and of certain other substances to foods. OJ L 404, 30.12.2006, p. 26. 
7 Directive 2002/46/EC of the European Parliament and of the Council of 10 June 2002 on the approximation of the laws of 
the Member States relating to food supplements. OJ L 183, 12.7.2002, p. 51. 
8 Commission Directive 2006/141/EC of 22 December 2006 on infant formulae and follow-on formulae and amending 
Directive 1999/21/EC, OJ L 401, 30.12.2006, p. 1.  
9 Commission Directive 2006/125/EC of 5 December 2006 on processed cereal-based foods and baby foods for infants and 
young children, OJ L 339, 06.12.2006, p. 16. 
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assessment, and was missing for all included countries for 599 consumed food items, to which either a 
value from another food (if the food with the missing value was consumed frequently or in high 
quantities or belonged to a food group with a high zinc concentration) or a zero value (otherwise) was 
attributed. 
After consistency checks and replacement of missing values for zinc in the EFSA Food Composition 
Database, zinc intake was calculated in mg/day and mg/MJ for males (Appendix C) and females 
(Appendix D). Zinc intake calculations were performed only on subjects with at least two reporting 
days. Food consumption data in children were provided by nine studies, and data on adults were 
provided by eight studies, including one on pregnant women and adolescents. EFSA’s estimates are 
based on consumption of foods, either fortified or not (i.e. without dietary supplements). 
Average zinc intake ranged from 4.6 to 6.2 mg/day (1.1–1.5 mg/MJ) in children aged one to less than 
three years, from 5.5 to 9.3 mg/day (0.9–1.5 mg/MJ) in children aged 3 to < 10 years, from 6.8 to 
14.5 mg/day (1.0–1.5 mg/MJ) in adolescents (10 to < 18 years) and from 8.0 to 14.0 mg/day (1.1–
1.7 mg/MJ) in adults. Average daily intake (but not energy-adjusted intake) was, in most cases, 
slightly higher in males (see Appendix C) than in females (see Appendix D), mainly because of the 
larger quantities of food consumed per day. 
The main food groups contributing to zinc intake were meat and meat products, grains and grain-based 
products, and milk and dairy products. Other food groups contributing to zinc intake were composite 
dishes in the Netherlands, Sweden and the UK; vegetables and vegetable products in Italy; and fish 
and fish products in Italy and Sweden (see Appendices D and E). The differences in the main 
contributors to zinc intake between males and females were small. 
EFSA’s zinc intake estimates in mg/day were compared with published intake values from the same 
survey and dataset and the same age class using the German EsKiMo and VELS surveys in children 
(Kersting and Clausen, 2003; Mensink et al., 2007), the DIPP study in Finnish children (Kyttälä et al., 
2008; Kyttälä et al., 2010), the study in Finnish adolescents (Hoppu et al., 2010), the French national 
INCA2 survey (Afssa, 2009), the Irish NANS Survey (IUNA, 2011), the FINDIET 2012 Survey 
(Helldán et al., 2013), the Italian INRAN-SCAI Survey (Sette et al., 2011), the Dutch National Dietary 
Survey (van Rossum et al., 2011), the Swedish national survey Riksmaten (Amcoff et al., 2012) and 
the UK NDNS Survey (Bates et al., 2012) (Table 2). 
Table 2:  EFSA’s average daily zinc intake estimates, expressed as percentages of intakes reported 
in the literature 
Country % of published intake (% range over different age classes in a specific survey) 
Finland  88–104 (DIPP, for ages ≥ 1 year), 102–103 (Finnish adolescents), 91–96 (FINDIET 2012) 
France 93–112 (INCA2) 
Germany 95–104 (VELS children), 110–111 (EsKiMo) 
Ireland  112–120 (NANS) 
Italy 89–93 (INRAN-SCAI) 
NL 101–105 (Dutch National Dietary Survey) 
Sweden 105–109 (Riksmaten) 
UK 99–108 (NDNS–Rolling Programme, Years 1–3, for ages ≥ 3 years) 
Comparisons had inherent limitations in the case of the UK survey, as published intake values covered 
only the first two years of the survey, whereas EFSA data from the UK cover the first three years. In 
the survey in Finnish adolescents, published values were for two consecutive days of dietary recall, 
whereas EFSA data comprised two 48-hour dietary recalls. Likewise, comparisons were not optimal 
for the EsKiMo study and the DIPP study, because the published intake values included supplement 
consumption, whereas the EFSA estimates are based on food consumption only. However, according 
to these publications (Mensink et al., 2007; Kyttälä et al., 2010), zinc supplements were not among the 
major contributors to zinc intakes in these age classes. A comparison could not be undertaken for the 
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Latvian survey, as no matching publication was available. The EFSA estimates differed by up to about 
10 % from the published values in Finland, France, Germany, Italy, the Netherlands, Sweden and the 
UK. The estimated Irish intakes were shown to be an overestimation of 12–20 %, which may partly be 
caused by the fact that data provided on composite dishes were almost completely disaggregated to the 
ingredient level, thereby not capturing possible zinc losses due to processing. Uncertainties in the 
estimates of all countries may be caused by inaccuracies in mapping food consumption data according 
to the FoodEx2 classification; by inaccuracies in analysing or estimating zinc composition for the food 
composition table, due to the use of borrowed zinc values from other countries in the food 
composition database; and by replacing missing zinc values with values of similar foods or food 
groups in the zinc intake estimation process. These uncertainties may, in principle, cause estimates of 
zinc intake that are either too high or too low. 
3.3. Dietary phytate intake 
The range of dietary phytate intake in the few European countries for which English-language data are 
available varies widely (Schlemmer et al., 2009; Amirabdollahian and Ash, 2010; Prynne et al., 2010). 
For example, median phytate intake reported in the UK based on the representative National Diet and 
Nutrition Survey ranged from 692 to 948 mg/day in men and from 538 to 807 mg/day in women of 
various age groups (Amirabdollahian and Ash, 2010), whereas lower intakes have been reported from 
studies in Scandinavian countries (Brune et al., 1989; Plaami and Kumpulainen, 1996) and in Italy 
(Carnovale et al., 1987) (see Appendix G). 
The wide variation in phytate intake can partially be explained by differences in dietary patterns 
within and between countries; for example, dietary patterns dominated by plant foods are accompanied 
by a higher phytate intake. Besides dietary patterns, differences in food processing that can affect the 
phytate content of foods consumed, as well as methodological problems associated with phytate intake 
assessment, also contribute to variation among surveys. It has been estimated that adults ingest about 
300 to 800 mg/day of phytate with a mixed diet and that the phytate intake increases to 700 to 
1 400 mg/day for mixed diets with a high proportion of unrefined cereal grain products and legumes 
(Ingelmann et al., 1993; Schlemmer, 1995), whereas dietary phytate intake may be as high as 1 600 to 
2 500 mg/day in adults on vegetarian diets (Bindra and Gibson, 1986; Ellis et al., 1987; Khokhar and 
Pushpanjali, 1994). 
4. Overview of Dietary Reference Values and recommendations 
4.1. Adults 
The Nordic countries (NNR, 2004) estimated zinc requirements using the factorial method. For the 
estimate of endogenous faecal losses and losses via other routes, the figures of the US Institute of 
Medicine (IOM, 2001) were used. Endogenous intestinal losses were estimated to be 1.4 mg/day for 
both sexes based on observed losses at low intake (1–5 mg/day). Thus, it was assumed that 2.67 and 
2.4 mg/day for men and women, respectively, have to be absorbed in order to replace all losses. 
Absorption efficiency of zinc from a mixed animal and vegetable protein diet, which is usually 
consumed in the Nordic countries, was assumed to be 40 %. The AR of zinc was therefore set at 6.4 
and 5.7 mg/day, respectively, for men and women. The inter-individual variation in requirement was 
set at 15 %, resulting in recommended intakes of 9 mg/day for men and 7 mg/day for women. It was 
noted that this recommended intake probably has a high safety margin, as the ability to adapt to lower 
intake appears to be substantial. For NNR 2012, recommended intakes from NNR 2004 were 
maintained since no strong evidence has emerged to justify a change (Nordic Council of Ministers, 
2014). 
The German-speaking countries (D-A-CH, 2013) estimated obligatory daily zinc losses to be 2.2 mg 
in men and 1.6 mg in women based on data from King and Turnlund (1989). To replace these losses, 
an AR of 7.5 mg/day for men and 5.5 mg/day for women was calculated, assuming a mean zinc 
absorption efficiency of 30 % from mixed diets (Milne et al., 1983; Taylor et al., 1991). When twice 
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the coefficient of variation (CV) of 15 % was added to the AR, the recommended intakes were 
10 mg/day for men and 7 mg/day for women. 
IOM (2001) applied a factorial approach to calculate the minimal quantity of absorbed zinc necessary 
to replace the daily excretion of endogenous zinc. Losses via routes other than the intestine were 
regarded as unrelated to dietary zinc intake over a wide range encompassing zinc requirements. They 
were calculated to be 1.27 mg/day for men and 1.0 mg/day for women, considering data on average 
urinary excretion, integumental losses, and losses in semen or menstrual losses, respectively. IOM 
determined the correlation between the losses through excretion of endogenous zinc via the intestine 
and the quantity of zinc absorbed based on balance studies (Jackson et al., 1984; Turnlund et al., 1984; 
Wada et al., 1985; Turnlund et al., 1986; Taylor et al., 1991; Hunt J et al., 1992; Lee et al., 1993) and, 
taking into account a constant for non-faecal endogenous losses, calculated the average total minimal 
quantity of absorbed zinc required to offset losses as 3.84 mg/day for men and 3.3 mg/day for women. 
Considering the asymptotic regression of absorbed zinc on zinc intake observed in the balance studies, 
Estimated Average Requirements (EARs) of 9.4 mg/day for men and 6.8 mg/day for women were 
determined, corresponding to average fractional absorption of zinc (FAZ) of 0.41 and 0.48 for men 
and women, respectively. IOM noted that such EARs are supported by data from zinc depletion 
studies considering changes in functional endpoints (Wada and King, 1986; Grider et al., 1990; Beck 
et al., 1997b; Beck et al., 1997a) and a study on biochemical zinc status in healthy women (Gibson et 
al., 2000). Recommended Dietary Allowances (RDAs) of 11 mg/day for men and 8 mg/day for women 
were set by adding twice the CV of 10 % to the EARs. 
WHO/FAO (2004) applied a factorial approach, which involved totalling the requirements for tissue 
maintenance, metabolism and endogenous losses. The body’s ability to adapt to different levels of zinc 
intake was taken into consideration by defining the normative requirement for absorbed zinc as the 
obligatory loss during the early phase of zinc depletion before adaptive reductions in excretion take 
place. The normative requirements for absorbed zinc were estimated to be 1.4 mg/day for men and 
1.0 mg/day for women by adding estimations of faecal, urinary and skin losses (data derived from 
Milne et al. (1983); Milne et al. (1987); Taylor et al. (1991)). To translate these estimates into 
requirements for dietary zinc, the influence of the nature of the diet (i.e. its content of promoters and 
inhibitors of zinc absorption) and the efficiency of absorption of potentially available zinc were 
considered. Overall, three categories of diets were distinguished, characterised by high, moderate and 
low zinc bioavailability, and the absorption efficiency figures that were estimated to be adequate to 
meet the normative requirements for absorbed zinc were 50 %, 30 % and 15 %, respectively. 
Corresponding average individual dietary requirements were estimated to be 36, 59 and 119 µg/kg 
body weight per day for women and 43, 72 and 144 µg/kg body weight per day for men. Assuming an 
inter-individual variation of zinc requirements of 25 %, the recommended nutrient intakes are 3.0, 4.9 
and 9.8 mg/day for women and 4.2, 7.0 and 14.0 mg/day for men for diets of high, moderate and low 
zinc bioavailability, respectively. 
Afssa (2001) set two levels of recommended intakes, depending on the dietary content of products of 
animal origin. A daily intake of 7 mg/day for women and 9 mg/day for men was recommended if the 
diet contains relatively high amounts of products of animal origin (estimated intestinal zinc absorption 
of 30 %). An increased daily intake of 12 mg/day for women and 14 mg/day for men was proposed if 
the diet contained relatively low amounts of products of animal origin (estimated intestinal absorption 
of 20 %). 
The Netherlands Food and Nutrition Council (1992) applied a factorial approach. Total zinc losses 
were estimated to be 1.3–1.9 mg/day for men and 1.1–1.7 mg/day for women, considering data on 
average urinary excretion, integumental losses and additional losses in semen for men. Menstrual zinc 
losses were considered negligible. Minimum requirements were estimated to be 5.2–7.6 mg/day for 
men and 4.4–6.8 mg/day for women, applying an estimated average absorption efficiency of 25 %. 
The council proposed adequate ranges of intakes of 7.0–10.0 mg/day for men and 6.0–9.0 mg/day for 
women, assuming an inter-individual variation in zinc losses of 20 %. 
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The UK Committee on Medical Aspects of Food Policy (COMA) (DH, 1991) assessed the zinc 
requirement on the basis of factorial analyses using measurements of basal losses during metabolic 
studies of deprivation, the turnover time of radiolabelled endogenous zinc pools, and deduction from 
metabolic studies of patients receiving total parenteral nutrition. Minimal zinc losses in the order of 
2.2 and 1.6 mg/day in men and women, respectively, were estimated, considering data on basal faecal 
and urinary losses, and on losses via skin, hair, semen and menstruation, where appropriate (Hambidge 
et al., 1986; King and Turnlund, 1989; Taylor et al., 1991). Assuming an absorption efficiency of 
30 %, these figures translate into EARs of 7.3 mg/day in men and 5.5 mg/day in women. Reference 
Nutrient Intakes (RNIs) of 9.5 and 7.0 mg/day were set for men and women, respectively. Based on 
the same considerations, the SCF also proposed PRIs of 9.5 mg/day for men and 7.0 mg/day for 
women (SCF, 1993). 
Table 3:  Overview of Dietary Reference Values for zinc for adults 
 NNR 
(2012) 
D-A-CH 
(2013) 
WHO/FAO 
(2004) 
Afssa 
(2001) (a) 
IOM 
(2001) 
SCF 
(1993) 
NL 
(1992) (b) 
DH 
(1991)
High 
BA 
(50 %) 
Moderate 
BA (30 %)
Low 
BA 
(15 %)
IA of 
20 %
IA of 
30 %
Age 
(years) 
≥ 18 ≥ 19 ≥ 19 ≥ 19 ≥ 19 ≥ 20 ≥ 20 ≥ 19 ≥ 18 ≥ 19 ≥ 19 
PRI men 
(mg/day) 
9 10 4.2 7.0 14.0 14 9 11 9.5 7–10 9.5 
PRI 
women 
(mg/day) 
7 7 3.0 4.9 9.8 12 7 8 7 6–9 7.0 
NL, Netherlands Food and Nutrition Council; BA, bioavailability; IA, intestinal absorption. 
(a): The values vary according to the bioavailability of zinc from the diet: for predominantly vegetarian diets, a 
bioavailability of 20 % is assumed, and, for balanced diets rich in animal products, including meat products, a 
bioavailability of 30 % is assumed. 
(b): Adequate range of daily intake. 
4.2. Infants and children 
The Nordic countries (NNR, 2004) noted that data on endogenous losses of zinc at different levels of 
intake are almost completely lacking for children. It was also noted that, in relation to body weight, 
children appear to have larger losses of zinc than adults. The need for growth was estimated to be 
175 µg/kg body weight per day during the first month of life, decreasing to approximately 30 µg/kg 
body weight per day at 9–12 months of age (Krebs and Hambidge, 1986). For growing children, the 
need for zinc was based on basal losses of 0.1 mg/kg body weight per day and a zinc content in new 
tissue of 30 µg/g. For adolescents, growth was assumed to result in an average zinc content in new 
tissue of 23 µg/g, due to an increase in fat tissue with a lower zinc content than children. The 
physiological needs for rapidly growing adolescents were considered to be increased by 0.3–
0.4 mg/day. Applying the same principles as for adults, the recommended zinc intakes vary from 
2 mg/day in the youngest age group to 12 mg/day for adolescent boys. For NNR 2012, the 
recommended intakes from 2004 were kept unchanged (Nordic Council of Ministers, 2014).   
WHO/FAO (2004) considered evidence that the maintenance requirement in infants is influenced by 
the nature of the diet (Krebs and Hambidge, 1986; Krebs, 1993) and assumed endogenous losses of 
zinc to be 20 µg/kg body weight per day for human milk-fed infants and about 30–40 µg/kg body 
weight per day for infants fed formula or weaning foods. The estimated zinc requirements for infant 
growth were set at 120 and 140 µg/kg body weight per day for female and male infants, respectively, 
for the first three months of life. These values decreased to 33 µg/kg body weight per day for infants 
aged 6–12 months. A bioavailability of 80 % was assumed for exclusively breast-fed infants, and a 
bioavailability of 15 or 30 % was assumed for formula-fed infants, depending on the type of formula. 
For infants up to six months of age, it was assumed that the inter-individual variation of zinc 
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requirements is 12.5 % and is the same for breast-fed (derived from Vuori (1979b)) and formula-fed 
infants. After that age, a CV of 25 % was assumed. For other age groups, an average loss of 
0.57 µg/kcal of resting energy expenditure (REE) was derived by extrapolating from the adult REE 
values. For children aged 1–10 years, the requirements for growth were based on the assumption that 
new tissue contains 30 µg zinc/g. For adolescent growth, a tissue zinc content of 23 µg/g was 
assumed. Taking into account that pubertal growth spurts increase physiological zinc requirements 
substantially, growth of adolescent males was assumed to correspond to an increase in body zinc 
requirement of about 0.5 mg/day. 
For infants aged 0–6 months, IOM (2001) set an Adequate Intake (AI) of 2.0 mg/day, which reflects 
the observed mean zinc intake of infants exclusively fed human milk. Human milk alone was 
considered an inadequate source of zinc after the first six months of life, and EARs for older infants 
and children were based on the factorial approach. Excretion of endogenous zinc was estimated by 
extrapolation from measured values for either adults or younger infants. Requirements for growth 
were derived from chemical analyses of zinc concentrations of infant and adult tissues (Widdowson 
and Dickerson, 1964) and average daily accretion of new tissue (Kuczmarski et al., 2000). For pre-
adolescent children (seven months to 13 years), a conservative FAZ of 0.3 was applied (Fairweather-
Tait et al., 1995; Davidsson et al., 1996), whereas a FAZ of 0.4 was used for adolescents (14 to 18 
years). IOM noted that growth data from supplementation studies with zinc in children aged 7 to 12 
months (Walravens et al., 1989) and four to eight years (Walravens et al., 1983; Gibson et al., 1989) 
were consistent with the EARs derived from the factorial approach. Corresponding RDAs were set by 
adding twice the CV of 10 % to the EARs. 
The Netherlands Food and Nutrition Council (1992) applied a factorial approach. Total zinc losses 
were extrapolated from adults on the basis of metabolic weight (kg0.75). For the first half year of life, 
the requirement for growth was estimated at 400 µg/day (Widdowson and Dickerson, 1964; 
Sandstead, 1973; WHO, 1973), on the basis of the increase in fat-free body mass and the zinc content 
per kg of fat-free body mass. An estimated average absorption efficiency of 25 % was applied to 
derive the minimum dietary requirements. Corresponding adequate ranges of intakes were set, 
assuming inter-individual variations of 20 % in zinc loss and 15 % in zinc requirement for growth. 
The UK COMA (DH, 1991) used a factorial approach to calculate daily zinc requirements for infants 
and children. Growth increments were estimated on the basis of growth progressing along the 50th 
percentile and on a lean tissue zinc content of 30 µg/g. Urine and sweat zinc losses were taken as 10 
and 20 µg/kg body weight per day, respectively, and faecal losses as 77 µg/kg body weight per day. 
This led to a daily requirement of absorbed zinc of 1.0 mg. Taking into account an absorption 
efficiency of 30 % from infant formula, an EAR of 3.3 mg/day was derived. The RNI was set at 
4 mg/day by adding twice the CV of 10 % to the EAR. For children over one year of age, RNIs were 
based on interpolated basal losses from adults and calculated increments for growth, assuming an 
absorption efficiency of 30 %. The SCF set the PRIs for infants and children based on the same 
approaches (SCF, 1993). 
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Table 4:  Overview of Dietary Reference Values for zinc for children from four months of age 
 NNR 
(2012) 
D-A-CH 
(2013) 
WHO/FAO (2004) Afssa (2001) (a) IOM 
(2001) 
SCF 
(1993) 
NL 
(1992)
 (b) 
DH 
(1991)High 
BA 
(50 %) 
Moderate 
BA 
(30 %) 
Low 
BA 
(15 %)
IA of 
20 % 
IA of 
30 % 
Age 
(months) 
6–11 4– < 12 7–12 7–12 7–12   7–12 6–11 6–12 7–12 
PRI 
(mg/day) 
5 2 0.8 (c), 
2.5 (d) 
4.1 8.4   3 4 3–4 5 
Age (years) 1– < 2 1– < 4 1–3 1–3 1–3 1–3 1–3 1–3 1–3 1–4 1–3 
PRI 
(mg/day) 
5 3 2.4 4.1 8.3 8 5 3 4 3–4 5 
Age (years) 2–5 4– < 7 4–6 4–6 4–6 4–9 4–9 4–8 4–6 4–7 4–6 
PRI 
(mg/day) 
6 5 2.9 4.8 9.6 11 6 5 6 4–5 6.5 
Age (years) 6–9 7– < 10 7–9 7–9 7–9   9–13 7–10 7–10 7–10 
PRI 
(mg/day) 
7 7 3.3 5.6 11.2   8 7 4–6 7 
Age (years) 10–13 10– < 13 10–18 10–18 10–18 10–12 10–12 14–18 11–14 10–13 11–14
PRI: boys 
(mg/day) 
11 9 5.1 8.6 17.1 14 9 11 9 5–7 9 
PRI: girls 
(mg/day) 
8 7 4.3 7.2 14.4 13 9 9 9 5–7 9 
Age (years) 14–17 13– < 15    13–19 13–19  15–17 13–16 15–18
PRI: boys 
(mg/day) 
12 9.5    14 11  9 7–10 9.5 
PRI: girls 
(mg/day) 
9 7    11 9  7 7–10 7.0 
Age (years)  15– < 19        16–19  
PRI: boys 
(mg/day) 
 10        8–11  
PRI: girls 
(mg/day) 
 7        6–9  
NL, Netherlands Food and Nutrition Council; BA, bioavailability; IA, intestinal absorption. 
(a): The values vary according to the bioavailability of zinc from the diet: for predominantly vegetarian diets, a 
bioavailability of 20 % is assumed, and, for balanced diets rich in animal products, including meat products, a 
bioavailability of 30 % is assumed. 
(b): Adequate range of daily intake. 
(c): Exclusively human milk-fed infants. 
(d): Not applicable to infants consuming human milk only. 
4.3. Pregnancy 
The Nordic countries (Nordic Council of Ministers, 2014) considered that the total need for zinc 
during pregnancy for the fetus, placenta and other tissues is approximately 100 mg (King, 2000), and 
that studies on whether or not homeostatic adjustments occur during pregnancy are inconclusive 
(Swanson and King, 1982; Fung et al., 1997). The recommended intakes were based on an assumed 
increase of the physiological requirement by 0.7 mg/day. With adjustment for absorption, the 
additional recommended intake was set at 2 mg/day. 
The German-speaking countries (D-A-CH, 2013) considered that the average additional requirement 
of absorbed zinc during the second half of pregnancy is 0.8 mg/day and recommended an additional 
zinc intake of 3 mg/day from the fourth month of pregnancy onwards. 
WHO/FAO (2004) considered an estimated amount of zinc retained during pregnancy of 100 mg 
(Lentner, 1984; Swanson and King, 1987). During the third trimester, the physiological requirement of 
zinc was assumed to be approximately twice as high as that of non-pregnant women. 
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Applying a factorial approach, IOM (2001) determined an additional requirement of 2.7 mg/day, 
considering the highest average daily rate of zinc accumulation by maternal and fetal tissues of 
0.73 mg observed during the fourth quarter of pregnancy (Swanson and King, 1987), and an estimated 
average FAZ of 0.27 (Turnlund et al., 1991; Hunt J et al., 1992; Sian et al., 1996; Fung et al., 1997; 
Hunt et al., 1998; Miller et al., 1998). EARs of 10 mg/day for pregnant adolescents aged 14–18 years 
and of 9.5 mg/day for pregnant women were derived, and RDAs were set at 12 mg/day and 
11 mg/day, respectively, by adding twice the CV of 10 % to the EARs and rounding to the nearest 
1 mg. 
The Netherlands Food and Nutrition Council (1992) considered extra zinc requirements of 0.6, 0.9 and 
1.0 mg/day during the first, second and third trimesters of pregnancy, respectively, according to WHO 
(1973), and set adequate ranges of intakes of 9–12 mg/day during the first trimester and of 11–
15 mg/day during the second and third trimesters. 
The UK COMA (DH, 1991) noted that, although there was evidence that extra zinc is required during 
pregnancy, studies have shown no increase in customary daily zinc intake by pregnant women and no 
benefit from zinc supplements (Mahomed et al., 1989). The committee considered it probable that, in 
healthy women, metabolic adaptation ensures an adequate transfer of zinc to the fetus, and no 
increment was proposed for pregnant women. The SCF (1993) adopted the same approach. 
Table 5:  Overview of Dietary Reference Values for zinc for pregnant women 
 NNR 
(2012) 
D-A-CH  
(2013) 
WHO/FAO (2004) Afssa (2001) (a) IOM 
(1998) 
SCF 
(1993) 
NL 
(1992) (b)
DH 
(1991)High 
BA 
(50 %) 
Moderate 
BA 
(30 %) 
Low 
BA 
(15 %)
IA of 
20 % 
IA of 
30 % 
Age 
(years) 
       14–18    
PRI 
(mg/day) 
9 10 (c) 3.4 (d) 5.5 (d) 11.0 (d) 16 (e) 11 (e) 12 7 9–12 (d) 7 
4.2 (f) 7.0 (f) 14.0 (f) 11–15 (f)
6.0 (g) 10.0 (g) 20.0 (g) 11–15 (g)
Age 
(years) 
       19–50    
PRI 
(mg/day) 
       11    
NL, Netherlands Food and Nutrition Council; BA, bioavailability; IA, intestinal absorption. 
(a): The values vary according to the bioavailability of zinc from the diet: for predominantly vegetarian diets, a 
bioavailability of 20 % is assumed, and, for balanced diets rich in animal products, including meat products, a 
bioavailability of 30 % is assumed. 
(b): Adequate range of daily intake. 
(c): From four months of age. 
(d): First trimester. 
(e): Increases during gestation; value is for the third trimester. 
(f): Second trimester. 
(g): Third trimester. 
4.4. Lactation 
The Nordic countries (Nordic Council of Ministers, 2014) considered milk zinc concentration to be 
2.5 mg/L in the first month of lactation and to fall to approximately 0.7 mg/L after four months (Krebs 
and Hambidge, 1986). An additional requirement of 1.7 mg/day for the replacement of zinc losses 
with human milk was assumed. Taking into account absorption efficiency, an additional dietary intake 
of 4 mg/day was recommended. 
Assuming that fully breast-fed infants receive 1 mg zinc/day with 0.75 L of human milk, the German-
speaking countries (D-A-CH, 2013) considered that the average additional requirement of absorbed 
zinc during lactation is 1 mg/day and recommended an additional zinc intake of 4 mg/day. 
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From data on maternal milk volume and milk zinc concentration, WHO/FAO (2004) estimated the 
daily output of zinc in milk to be 1.4 mg/day during the first three months of lactation, 0.8 mg/day 
from three to six months of lactation and 0.5 mg/day thereafter (Vuori, 1979b; Krebs and Hambidge, 
1986; Casey et al., 1989). In setting the requirements for early lactation (zero to three months post 
partum), it was assumed that around 0.5 mg/day is covered by postnatal involution of the uterus and 
from skeletal resorption. 
IOM (2001) estimated the losses of zinc in human milk to be 3 mg/L at four weeks and 1.2 mg/L at 24 
weeks post partum on the basis of observed average zinc concentrations in human milk (Moser-
Veillon and Reynolds, 1990; Krebs et al., 1995) and an average secretion of 0.78 L milk/day. IOM 
also took into account that zinc is released from the post partum involution of the uterus and the 
decreased maternal blood volume (King and Turnlund, 1989), and assumed that it is available for re-
utilisation. Overall, the average calculated increased requirement of absorbed zinc was 1.35 mg/day. 
Applying a FAZ of 0.377 during lactation (Fung et al., 1997), the additional zinc requirement was 
estimated to be 3.6 mg/day. 
To compensate for zinc transfer into breast milk, the Netherlands Food and Nutrition Council (1992) 
estimated an additional requirement of 2.4 mg/day during the first month of lactation, of 2.0 mg/day 
during the second and third months of lactation and of 1.2 mg/day thereafter (Vuori, 1979a; Ruz, 
1984; Casey et al., 1985). 
During lactation, the UK COMA (DH, 1991) proposed an increment of 6 mg/day during the initial 
four months of lactation and 2.5 mg/day thereafter, on the basis of a daily milk volume of 0.85 L and 
zinc losses of 2.13 and 0.94 mg/day, respectively. The SCF (1993) proposed an additional dietary 
intake of 5 mg/day during lactation to cover the amount of zinc transferred into milk. 
Table 6:  Overview of Dietary Reference Values for zinc for lactating women 
 NNR 
(2012) 
D-A-CH 
(2013) 
WHO/FAO (2004) Afssa 
(2001) (a) 
IOM 
(1998) 
SCF 
(1993) 
NL 
(1992) (b) 
DH 
(1991) 
High 
BA 
(50 %) 
Moderate 
BA 
(30 %) 
Low 
BA 
(15 %)
IA of 
20 %
IA of 
30 %
Age 
(years) 
       14–18    
PRI 
(mg/day) 
11 11 5.8 (c) 9.5 (c) 19.0 (c) 23 (d) 15 (d) 13 12 16–20 (c) + 6 (e) 
5.3 (f) 8.8 (f) 17.5 (f) 13–16 (g) + 2.5 (g)
4.3 (h) 7.2 (h) 14.4 (h)   
Age 
(years) 
       19–50    
PRI 
(mg/day) 
       12    
NL, Netherlands Food and Nutrition Council; BA, bioavailability; IA, intestinal absorption. 
(a): The values vary according to the bioavailability of zinc from the diet: for predominantly vegetarian diets, a 
bioavailability of 20 % is assumed, and, for balanced diets rich in animal products, including meat products, a 
bioavailability of 30 % is assumed. 
(b): Adequate range of daily intake. 
(c): Zero to three months post partum. 
(d): Decreases during lactation; values for the first month. 
(e): Zero to four months post partum. 
(f): Three to six months post partum. 
(g): After three (Netherlands)/four (UK) months post partum. 
(h): 6–12 months post partum. 
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5. Criteria (endpoints) on which to base Dietary Reference Values 
5.1. Indicators of adult zinc requirement 
The lack of sensitive specific biomarkers or clinical features of “mild” zinc deficiency precludes the 
possibility of using a dose–response approach for estimating zinc requirements. Theoretically, the 
traditional balance technique combined with urine and integumental zinc losses has the potential to 
provide information on zinc requirements. In practice, despite a long history of such measurements, 
this approach has not provided satisfactory results. The small difference obtained from subtracting 
total faecal excretion from total ingested zinc to derive net absorption detracts from the accuracy and 
reliability of this approach, and it does not provide information on true zinc absorption. The advent 
and progressive improvement of equipment and techniques for the application of zinc stable isotopes 
to studies of zinc homeostasis has progressively facilitated the application of a factorial approach in 
the estimation of zinc requirements. 
The estimation of zinc requirements by the factorial approach requires two stages. The first is the 
estimation of physiological requirements, defined as the minimum quantity of absorbed zinc necessary 
to match losses of endogenous zinc and to meet any additional requirements for absorbed zinc that 
may be necessary in lactation as well as for growth in healthy well-nourished infants and children and 
in pregnancy. The second stage is the determination of the quantity of dietary zinc available for 
absorption that is necessary to meet the physiological requirement. 
5.1.1. Physiological requirement 
5.1.1.1. Identification of studies, data extraction and assessment of methodological quality 
A total of 15 studies were identified from the published literature that included data on endogenous 
faecal zinc (EFZ) and total absorbed zinc (TAZ) for the estimation of physiological zinc requirement. 
Fourteen studies were identified by comprehensive literature searches in PubMed up to mid-February 
2014 using the following search string: zinc[TI] AND ((endogenous f*ecal) OR (intestinal excretion 
endogenous) OR (intestinal endogenous losses) OR isotope* OR compartmental OR extrinsic* OR 
balance) AND ((total absorbed) OR absorption OR retention OR depletion OR pool* OR metabolism), 
with a limit to human studies. One study was identified by hand-searching the reference list of studies 
retrieved by the comprehensive literature search. 
Inclusion criteria were the following: studies of healthy adults, whole-day isotope studies of true zinc 
absorption, studies with information on body weight of participants, and retrieval of individual data at 
time of final data analyses. Second stage exclusion criteria included physiologically implausible data 
for EFZ and evidence of clinical disease. 
After detailed review of all potential data and elimination of studies that had significant 
methodological limitations, the methodologies used in the studies included in the final analyses are 
considered to be reliable. For example, only studies that employed isotope tracer methods for 
determining zinc absorption were considered acceptable. 
5.1.1.2. Inclusion of studies 
For 15 studies, data from the individual study participants were supplied by the authors. Data quality 
was assessed initially based on whether or not data were physiologically plausible. Initial evaluation 
identified two study designs (compartmental modelling and faecal isotope dilution) that included 
intravenous administration of a zinc stable isotope tracer and its dilution in the faeces, i.e. isotopic 
labelling of the endogenous zinc appearing in the faeces, and which consistently provided 
physiologically plausible data. The quality of a third method involving isotopic measurement of 
absorption coupled with gastro-intestinal balance of non-labelled zinc was judged on the 
physiologically plausible results (see Section 5.1.1.3 and Appendix H). Information extracted from the 
studies were total dietary zinc (µmol/day or mg/day), total dietary phytate (µmol/day or mg/day), total 
absorbed zinc (µmol/day or mg/day), faecal excretion of endogenous zinc (µmol/day or mg/day), daily 
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urinary zinc excretion (µmol/day or mg/day), subject body weight (kg) and subject height (m) (see 
also Appendix I). 
5.1.1.3. Inclusion of individual data 
Thirteen individual data points, all from studies utilising the zinc absorption–intestinal balance 
technique, had physiologically impossible negative values for EFZ, and accordingly were omitted 
from subsequent calculations. After omitting these individual data points, the remaining data from 
these studies (Wada et al., 1985; Hunt J et al., 1992; Hunt et al., 1995; Hunt et al., 1998) and the data 
from the study of Sandstrom et al. (2000) were evaluated in comparison to the data from studies which 
had no negative EFZ values, the majority of which were data from studies using isotope tracer 
methods (isotope dilution, compartmental modelling) to directly measure EFZ and were, therefore, the 
most reliable. The EFZ data in question were found to differ from the standard data in distribution and 
relationships to other variables, bringing into question their accuracy (see Appendix H for details). 
In view of the uncertainty about the accuracy of the EFZ results in particular studies (Wada et al., 
1985; Hunt J et al., 1992; Hunt et al., 1995; Hunt et al., 1998; Sandstrom et al., 2000), the Panel 
decided to exclude data from these studies from subsequent consideration. Also excluded was one 
participant in the study of Taylor et al. (1991), who had biochemical and haematological indices of 
hepatitis possibly caused by alcohol abuse. Exclusion involved a total of 103 data points (more details 
on the preliminary data analysis are given in Appendix H). 
The final numbers of subjects contributing data to the estimate of physiological zinc requirements 
were 31 males and 54 females from a total of 10 studies. These included data from all available 
published studies that contained the data required, including a study in China (Sian et al., 1996) that 
had results that fit well with data from studies in the USA and Europe. Although several studies used 
semipurified formula diets, in most studies, the diets were composed of conventional foods, sometimes 
based on the habitual diets of the subjects. The period of time during which the subjects consumed 
these constant diets prior to the isotope studies varied from five days to five weeks, although seven 
days was the most common duration. Relevant individual data for the 85 subjects included in the final 
estimates are given in Appendix I. Dietary zinc intake of subjects ranged from 0.8 to 29 mg/day (see 
Appendix I). Dietary phytate intake was available for some of the studies using conventional food. 
Mean phytate intake reported in 4 of the 10 studies ranged from 585 to 835 mg/day (see Appendix I). 
5.1.1.4. Estimation of endogenous zinc losses 
Total endogenous zinc losses were calculated as the sum of losses via faeces, urine, combined 
integument and sweat (0.5 mg and 0.3 mg/day for men and women, respectively; see explanation 
below); semen (0.1 mg/day (Hunt CD et al., 1992; Johnson et al., 1993)); and menses (0.01 mg/day 
(Hess et al., 1977)), of which endogenous faecal zinc is the major component. Urinary zinc losses 
were reported for 57 of the 85 subjects. For the remaining 28 individuals, estimated urinary zinc losses 
based on sex were used. The estimated mean urinary zinc losses were 0.5 mg/day for men and 
0.3 mg/day for women. These were the averages of the 53 reported values (22 men, 31 women) for 
subjects in normal zinc status. Integumental and sweat zinc losses were estimated from published 
studies. An estimate of 0.5 mg/day for men was obtained from studies of whole body surface zinc 
losses in men (Jacob et al., 1981; Milne et al., 1983; Johnson et al., 1993). The estimate of 0.3 mg/day 
for women was calculated by multiplying the value for men by the female to male ratio of sweat zinc 
losses observed in studies of whole body sweat zinc losses and whole body sweat rates in men and 
women (Cohn and Emmett, 1978; Avellini et al., 1980; Frye and Kamon, 1983; Tipton et al., 1993; 
DeRuisseau et al., 2002; Hazelhurst and Claassen, 2006). These studies reported female to male ratios 
for sweat zinc loss rates between 0.5 and 0.7, while sweat zinc concentrations were similar. 
5.1.1.5. Modelling of zinc requirements 
The assumptions that the regression errors were normally distributed and exhibited constant variance, 
and that the model was valid, were checked primarily by visual examination of plots of the residuals. 
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Both the raw residuals and the externally studentised residuals were examined. Normality of the 
residuals was also tested with the D’Agostino–Pearson and Shapiro–Wilk tests. Externally studentised 
residuals were also examined for outliers. The variance inflation factor was used to evaluate 
multicollinearity. Details of the regression diagnostics are provided in Appendix J. 
A multiple regression analysis was used to evaluate the relationship of TAZ with (TAZ – total 
endogenous zinc losses), the predictor variable of interest, and with sex and body size as covariates. A 
major finding from this analysis was that TAZ varies significantly with body size expressed as weight, 
height, body mass index (BMI) or surface area. Each of the body size variables was made a covariate 
along with (TAZ – total endogenous zinc losses) in four separate regression models. In each case, the 
body size variable was significant, with p-values < 0.001, except for BMI, which had a p-value of 
0.013. The R2 values for the models with body weight, height, BMI and body surface area variables 
were 0.46, 0.42, 0.37 and 0.47, respectively. A variety of other unmeasured/unmeasurable variables 
presumably also contributed, ranging from inter-/intra-research facility variation to possible biological 
factors, for example the extent of up- or down-regulation of zinc transporters and other proteins 
involved in the absorption of zinc by the enterocyte, or variations in body zinc stores. The variable for 
sex was entered in each model. With the exception of BMI, none of the models demonstrated a 
significant sex effect, as sex differences were apparently accounted for by the body size covariate. In 
the BMI model, sex was a significant predictor (p-value: 0.011). The equation with the covariate body 
weight will be used for reasons of convenience and accuracy of measurement. The equation resulting 
from a least-squares fit to the body weight data, and which therefore links TAZ to body weight and the 
difference of TAZ minus total endogenous zinc losses, is the following Equation 1: 
TAZ [mg/day] = 0.642 + 0.038 × body weight [kg] + 0.716 × (TAZ – total endogenous zinc losses [mg/day]) 
Details of parameter estimates for the model corresponding to Equation 1 are shown in Table 7. 
Table 7:  Details of parameter estimates for the model describing the relationship between TAZ and 
the difference between TAZ and total endogenous zinc losses, as well as body size, corresponding to 
Equation 1 above 
Parameter Estimate 95 % confidence limits p-value 
Intercept 0.642 –0.403, 1.687 0.23 
Body weight 0.038   0.022, 0.054 < 0.0001 
TAZ – total endogenous zinc losses 0.716   0.512, 0.919 < 0.0001 
TAZ, total absorbed zinc. 
Examination of the residuals indicated that errors were normally distributed and exhibited constant 
variance, and that there was no deviation of the model from the data. One outlier with an externally 
studentised residual of 3.7 was observed. Re-examination of the source of the outlier indicated no 
basis for its removal; therefore, the outlier was retained. There was no evidence of collinearity of 
predictors. 
As mentioned below, the residuals did not indicate any deviation from the linear model. Nonetheless, 
polynomial terms were added to the model to explore the possibility of non-linear relationships. Only 
the second order polynomial of (TAZ – total endogenous zinc losses) was significant, but this was due 
to the presence of the outlying point (see above). When this point was momentarily removed, no 
significant polynomial terms were observed. It was therefore concluded that there was no evidence of 
non-linear relationships. 
The physiological requirement is equivalent to TAZ when the difference between absorbed zinc and 
total endogenous zinc losses equals zero at a given body weight. Therefore, the equation for estimating 
the physiological requirement (Equation 2) was derived from Equation 1 by removal of the (TAZ – 
total endogenous zinc losses) term: 
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Physiological zinc requirement [mg/day] = 0.642 + 0.038 × body weight [kg] (Equation 2) 
This equation is valid over a body weight range of roughly 40 to 100 kg. The size of the 95 % 
confidence interval (CI) for the estimation of the physiological requirements in Table 9 varies between 
± 0.23 and ± 0.25. 
Recent developments which have facilitated the estimation of physiological requirements include a 
simple model for estimating physiological requirements; the use of individual rather than mean data; 
recognition of the inaccuracies associated with the zinc absorption–intestinal balance technique in 
some studies, which were omitted from final estimates; recognition of the extent of the impact of body 
weight on the estimation of intestinal excretion of endogenous zinc and, therefore, of physiological 
requirements; and recognition of the absence of a sex effect on endogenous faecal zinc losses beyond 
that accounted for by differences in body weight. 
5.1.2. Estimation of dietary zinc intake to meet physiological requirement 
Although experimental data are still limited (Hambidge et al., 2010), there are also theoretical reasons 
for supporting the conclusion that the relationship between TAZ and total dietary zinc (TDZ) is most 
appropriately fitted with saturation response modelling. Therefore, the intercept of the TAZ necessary 
to meet physiological requirements with the saturation response model (Morgan et al., 1975) for the 
population studied should give the AR for that population. Saturation response modelling is based on 
the assumption that zinc absorption is a carrier-mediated, saturable process, and this is used to 
characterise the relationship between the quantity of zinc absorbed and the quantity of zinc ingested. It 
is accomplished by fitting one of several appropriate models to data from isotope tracer studies of zinc 
absorption using non-linear regression analysis. 
5.1.2.1. Effect of dietary zinc and phytate on absorbed zinc 
Although quantities vary greatly, diets containing plant foods, i.e. virtually all non-synthetic diets, 
contain phytate. The luminal contents of the duodenum and jejunum, especially phytate, can have a 
major impact on the percentage of zinc available for absorption (see Section 2.3.1). A trivariate model 
of TAZ as a function of dietary zinc and dietary phytate, based on saturation response modelling, has 
been found to account for more than 80 % of the variance in TAZ (Miller et al., 2007). 
5.1.2.2. Identification of studies, data extraction and assessment of methodological quality 
The data used in this trivariate model of the relationship between zinc absorption, and dietary zinc and 
phytate were 72 mean data points (reflecting 650 individual measurements) reported in 18 
publications. These are the data used in the development and early application of the model (Miller et 
al., 2007; Hambidge et al., 2010). The eligibility criteria were the following: studies of healthy adults, 
whole-day isotope studies of true zinc absorption, reporting measurements of TDZ, and total dietary 
phytate (TDP) and TAZ. No extensive literature search was performed in addition to that performed 
by the EURopean micronutrient RECommendations Aligned (EURRECA) network on factors 
affecting zinc bioavailability (Lowe et al., 2013); relevant publications were identified through 
knowledge of the existing work of the small number of investigators in this field of research and 
ongoing monitoring of the new literature. All the data came from research groups having extensive 
experience with the application of isotope tracer methods to the study of zinc absorption. A formal 
assessment of the quality of the data was not performed. The data are summarised in Appendix K. 
In all studies, participants ate controlled diets which contained known quantities of zinc and phytate 
(in many cases dietary calcium, iron and protein were also measured) in free-living and metabolic 
study environments. After varying lengths of time on the study diets, zinc stable or radio isotope 
tracers were administered, and enrichment was measured in body tissues and/or excretions to 
determine absorption. TDZ, TDP and TAZ data from these studies were used to develop the saturation 
response zinc absorption model (Miller et al., 2007). 
Dietary Reference Values for zinc
 
EFSA Journal 2014;12(10):3844 26
5.1.2.3. Modelling of the saturation response model 
The assumptions that the regression errors were normally distributed and exhibited constant variance, 
and that the model was valid, were checked primarily by visual examination of plots of the raw and 
standardised residuals. Normality of the residuals was also tested with the Shapiro–Wilk test. 
Residuals were also examined for outliers. 
The trivariate saturation response model is described by the following Equation 3: 
TAZ = 0.5∗ 0.033∗ 1+ TDP
0.68
⎛
⎝⎜
⎞
⎠⎟+0.091+TDZ − 0.033∗ 1+
TDP
0.68
⎛
⎝⎜
⎞
⎠⎟+0.091+TDZ
⎛
⎝⎜
⎞
⎠⎟
2
− 4∗0.091∗TDZ
⎛
⎝
⎜⎜
⎞
⎠
⎟⎟
 
where TAZ, TDP and TDZ are all in mmol/day. Units are converted to mg/day for plots and values 
reported in this Opinion. The range of TDP and TDZ of the data are 0–3 730 and 4–21 mg/day, 
respectively. The R2 of the fit was 0.81. The TAZ predicted by this model for the range of dietary zinc 
intake and selected dietary phytate levels is shown in Figure 1. 
Table 8:  Details of parameter estimates in the model on the relationship between zinc absorption, 
and dietary zinc and phytate corresponding to Equation 3 above 
Parameter Estimate 95 % confidence limits p-value 
Amax 0.091 0.079, 0.108 < 0.0001 
KP 0.678 0.290, 1.230 0.0029 
KT 0.033 0.014, 0.062 0.0038 
Amax, maximum possible absorbed zinc; KP, zinc–phytate binding equilibrium dissociation constant, rounded to 0.68 in 
Equation 3; KT, zinc–transporter binding equilibrium dissociation constant. 
 
Examination of the residuals indicated that errors were normally distributed and exhibited constant 
variance, and that there was no deviation of the model from the data. No outliers were detected. 
Details of the regression diagnostics are provided in Appendix J. 
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Figure 1:  Saturation response model predictions of total absorbed zinc (TAZ) for selected levels of 
dietary phytate. Portions of the curves between total dietary zinc (TDZ) values of 0 and 4 mg/day are 
extrapolated, as there were no zinc intake data within that range. A three-dimensional plot giving a 
complete range of TAZ as a function of TDZ and dietary phytate is given in Appendix L 
The dietary zinc intake required to meet the AR associated with different body weights (as predicted 
by the model described in Section 5.1.1.5) can be derived from the intersection of the respective 
physiological zinc requirements (identified on the axes of the absorbed zinc) with the saturation 
response model curve back-predicting the dietary zinc intake conditional to an expected level of 
phytate intake. 
This is illustrated in Figure 2, derived from the established model of phytate effect (Miller et al., 2007; 
Hambidge et al., 2010). The curves show the relationships of absorbed zinc to dietary zinc for dietary 
phytate levels of 0 and 900 mg/day, as predicted by the saturation response model. The horizontal 
dashed lines indicate the physiological requirements for males and females based on measured body 
weights of the subjects in the study (i.e. 59.1 kg for females and 72.7 kg for males, see Appendix I). 
Average dietary zinc requirements of these subjects are the corresponding dietary zinc intakes for the 
intersections of physiological zinc requirement values with the model curves. In Table 9, dietary zinc 
requirements, depending on the level of phytate intake, are shown for the subjects who contributed 
data to establish the physiological requirement model. 
Table 9:  Average dietary zinc requirements depending on phytate intake and body weight 
Body 
weight 
(kg) 
Physiological 
requirement 
(mg Zn/day) 
Average Requirement (mg Zn/day) for 
300 mg/day of 
dietary phytate 
600 mg/day of 
dietary phytate 
900 mg/day of 
dietary phytate 
1 200 mg/day of 
dietary phytate 
72.7 (a) 3.4 8.2 10.2 12.1 14.0 
59.1 (b) 2.9 6.3 7.7 9.1 10.4 
(a): Mean of the body weight data for men used to establish the physiological requirement (Equations 1 and 2) as described 
above (see Appendix I). 
(b): Mean of the body weight data for women used to establish the physiological requirement (Equations 1 and 2) as 
described above (see Appendix I). 
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Figure 2:  Relationships between absorbed zinc and dietary zinc for dietary phytate levels of 0 and 
900 mg/day, as predicted by the saturation response model 
No data are available for subjects older than 52 years. Although muscle mass decreases with 
increasing age, the turnover of zinc in muscle is slow. Without the relevant experimental data, the 
Panel considers that the basis for setting DRVs for older adults should be the same as for younger 
adults. 
5.2. Indicators of zinc requirements of children 
No specific indicators of zinc requirements are available for older infants and children. Linear growth 
is affected by zinc deficiency, but is far from being a specific indicator. 
5.3. Indicators of zinc requirements in pregnancy and lactation 
Although a variety of clinical features have been linked to zinc deficiency in pregnancy, these features 
are non-specific and have not been adequately substantiated. 
The additional need for zinc during pregnancy can be calculated from the weight of tissues gained 
during gestation and the concentration of zinc in those tissues. Widdowson and Dickerson (1964) 
measured the concentration of zinc in 24 human fetuses and full-term infants ranging in weight from 
0.75 to about 4 400 g. Using a mean measured zinc concentration of 18.4 µg/g fat-free tissue and 
measured fetal growth rates, Shaw (1979) calculated the rate of zinc accumulation by a human fetus 
growing along the 10th, 50th or 90th percentiles. The zinc accumulation rate for a fetus growing along 
the 50th percentile increased progressively from 0.21 mg/day at the 24th week of gestation to 
0.67 mg/day at the 36th week. In addition to the fetus, placental, uterine and mammary tissue, amniotic 
fluid and maternal blood are also gained during gestation. Hytten (1980) calculated the total weight of 
the pregnancy tissues at term. Based on the total weight of those tissues and their zinc concentrations, 
the total zinc requirement for pregnancy has been calculated to be about 100 mg (Swanson and King, 
1987). Approximately 60 % of the gain in zinc is associated with the fetus. The daily requirement for 
zinc in pregnancy above that of non-pregnant women can be calculated from the rate of tissue gain and 
the tissue zinc concentrations. The daily rates of zinc accumulation for the four quarters of pregnancy 
have been estimated to be 0.08, 0.24, 0.53 and 0.73 mg (Swanson and King, 1987). Taking into 
account the cessation of zinc losses with menstruation (equivalent to about 0.01 mg/day in 
menstruating women), Swanson and King (1987) estimated an additional physiological requirement 
for zinc in the second half of pregnancy of about 0.6 mg/day. When the average daily rates of zinc 
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accumulation for the four quarters of pregnancy (Swanson and King, 1987) are calculated, an 
additional physiological requirement of about 0.4 mg/day for the whole pregnancy is determined. 
In lactation, additional zinc may be needed to replace zinc secreted in breast milk. Losses of zinc in 
breast milk have been estimated, taking into account milk zinc concentrations and the amount of milk 
transferred, and are 2.52 mg/day for the first month, 1.37 mg/day for months 1 to 2 and 0.86 mg/day 
for months 3 to < 6 post partum (Brown et al., 2009) (see Section 2.3.6.3). Estimations for the 
additional zinc requirement in lactation also need to take into account redistribution of tissue zinc 
during postnatal re-adaptation to the non-pregnant state. Post partum involution of the uterus and 
decreased maternal blood volume have been estimated to release about 30 mg of zinc that has 
accumulated during pregnancy (King and Turnlund, 1989). The Panel assumed that this endogenous 
zinc is available for re-utilisation and decreases the additional amount of zinc required during the first 
month of lactation by 1 mg/day. This would reduce the additional physiological requirement to about 
1.5 mg/day for the first month of lactation. It has also been postulated that bone resorption in early 
lactation contributes to the amount of endogenous zinc available for secretion in breast milk (Moser-
Veillon, 1995; WHO, 1996), although the amount of zinc released from maternal bone during lactation 
has not been quantified (Donangelo and King, 2012). 
In pregnancy and, notably, in early lactation, up-regulation of zinc absorption has been reported (Fung 
et al., 1997; Harvey et al., 2007; Donangelo and King, 2012). For example, in two longitudinal studies 
of zinc homeostasis during pregnancy and lactation, FAZ increased 1.3-fold (p > 0.05) from pre-
conception to late pregnancy in 13 US women with a zinc intake of about 12 mg/day (Fung et al., 
1997) and 1.5-fold (p < 0.05) from early (10–12 weeks) to late (34–36 weeks) pregnancy in 10 
Brazilian women ingesting about 9 mg/day (Donangelo et al., 2005). FAZ increased 1.7-fold 
(p = 0.023) from pre-conception to lactation in the US women (Fung et al., 1997) and 1.4-fold 
(p < 0.05) from early pregnancy to lactation in the Brazilian women (Donangelo et al., 2005). There is 
some evidence to indicate that this up-regulation of zinc absorption may be sufficient to match 
increased requirements (Hambidge KM et al., unpublished). 
5.4. Zinc intake and long-term health consequences 
Mild to moderate dietary zinc depletion is a cause of several non-specific features including growth 
retardation, depressed immune function with susceptibility to infections, delayed wound healing, loss 
of appetite and loss of cognitive function. Severe restriction of dietary zinc is a cause of other clinical 
features including skin rashes. However, clinical features are non-specific and cannot be used for 
estimating DRVs. A systematic literature search and review for studies addressing zinc intake and 
health relationships was done by EURRECA; many studies were retrieved that addressed the 
relationship between zinc intake and outcomes such as cognitive and immune function, depression, 
anorexia, diabetes mellitus, ischaemic heart disease and cancer in adults. The authors concluded that 
studies were heterogeneous in their methodological approaches and outcomes assessed (Lowe et al., 
2013). The Panel concludes that the available evidence on zinc intake and health outcomes cannot be 
used for setting DRVs for zinc. 
6. Data on which to base Dietary Reference Values 
The data required to derive ARs and PRIs in different population groups are the zinc intake needed to 
replace endogenous losses and the quantity needed for growth and lactation, where appropriate. The 
factorial approach for deriving DRVs for zinc is used for all age groups. 
6.1. Adults 
As dietary zinc requirement depends on body weight and dietary phytate intake (Sections 5.1.1 and 
5.1.2), the Panel considers it appropriate to estimate ARs and PRIs for the range of mean/median 
dietary phytate intake observed in Europe. Thus, estimated ARs and PRIs are provided for phytate 
intake levels of 300, 600, 900 and 1 200 mg/day, which cover the range of mean/median phytate 
intake observed in European populations (see Section 3.3 and Appendix G) and thus reflect the variety 
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of European dietary patterns. Where population data on phytate intakes are available, ARs and PRIs 
could subsequently be adjusted using well-validated statistical models, an example of which has been 
used in this Opinion. 
Table 10 contains estimates on ARs and PRIs for zinc based on reference body weights for a BMI of 
22 kg/m2 (see Appendix 11 in EFSA NDA Panel (2013)). PRIs for adults were estimated as the zinc 
requirement of individuals with a body weight at the 97.5th percentile for reference body weights for 
men and women, as body weight is a strong determinant of the requirement for zinc and as this 
approach is considered to have less uncertainty than the mathematical application of a CV of between 
10 and 20 %. The PRIs based on the 97.5th percentile for reference body weights are equivalent to CVs 
for the ARs of between 10 and 14 %. 
Table 10:  Estimations of Average Requirements and Population Reference Intakes for zinc 
according to phytate intake and body weight 
Level of phytate intake (mg/day) Body weight (kg) Average Requirement 
(mg/day) 
Population Reference 
Intake (mg/day) (a) 
300 58.5 (b) 6.2 7.5 
68.1 (c) 7.5 9.4 
600 58.5 (b) 7.6 9.3 
68.1 (c) 9.3 11.7 
900 58.5 (b) 8.9 11.0 
68.1 (c) 11.0 14.0 
1 200 58.5 (b) 10.2 12.7 
68.1 (c) 12.7 16.3 
(a): Dietary zinc intake of subjects with a body weight at the 97.5th percentile of the reference body weights (i.e. 79.4 kg for 
men and 68.1 kg for women). 
(b): Median body weight of 18- to 79-year-old women based on measured body heights of 19 969 women in 13 European 
Union Member States and assuming a body mass index of 22 kg/m2 (see Appendix 11 in EFSA NDA Panel (2013)). At 
this body weight, the physiological zinc requirement is 2.9 mg/day. 
(c): Median body weight of 18- to 79-year-old men based on measured body heights of 16 500 men in 13 European Union 
Member States and assuming a body mass index of 22 kg/m2 (see Appendix 11 in EFSA NDA Panel (2013)). At this 
body weight, the physiological zinc requirement is 3.2 mg/day. 
6.2. Infants and children 
Estimation of DRVs for zinc uses a factorial approach taking into account endogenous zinc losses via 
urine, sweat and integument, faeces and, in adolescent boys and girls, semen and menses, respectively, 
as well as zinc required for the synthesis of new tissue for growth. 
6.2.1. Methodology 
6.2.1.1. Urinary and integumental zinc losses 
After early infancy, urinary excretion rates for children on a body weight basis seem to differ very 
little from adult values (Krebs and Hambidge, 1986). Thus, for infants aged 7 to 11 months and 
children from one year of age, data for urinary losses were extrapolated from adult values (see Section 
2.3.6.2) using isometric scaling, i.e. linear with body weight. For this, reference body weights based 
on the WHO Multicentre Growth Reference Study Group (2006) were used for infants and young 
children and based on van Buuren et al. (2012) for older children. For the age classes shown in Table 
10, median body weights at mid-point ages were chosen, i.e. at age nine months and 2, 5, 8.5, 12.5 and 
16 years. 
Integumental zinc losses were estimated from adult values (see Section 2.3.6.2) using allometric 
scaling, i.e. body weight to the power of 0.67 as a proxy for body surface area. 
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6.2.1.2. Endogenous faecal zinc losses 
In infants aged two to four months, the average intestinal excretion of endogenous zinc in exclusively 
breast-fed infants was approximately 50 µg/kg body weight per day (Krebs et al., 1996). For infants 
receiving complementary foods in addition to infant formula or human milk, endogenous faecal losses 
of 40 µg/kg body weight per day were assumed by WHO (1996) and WHO/FAO (2004). This figure 
was thus used to calculate daily EFZ by multiplication with infants’ reference body weights. 
Linear regression analysis of EFZ versus body weight (kg) for the subjects contributing data to the 
adult estimates (see Section 5.1.1), for 43 young children aged 19 to 25 months from China (Sheng et 
al., 2006) and from a study in 45 infants aged 9 to 10 months in the USA (Krebs N et al., 
unpublished), gives the following equation: 
EFZ [mg Zn/day] = 0.0318 × body weight [kg] + 0.362, with R2 = 0.75 (Equation 4) 
This equation was used to estimate EFZ for children from one year of age. 
6.2.1.3. Zinc losses in menses and semen 
Zinc losses in menses and semen of 0.01 and 0.1 mg/day, respectively, have been assumed (see 
Section 5.1.1.4). The mean age of menarche in the European Union (EU) has been reported to be 12.7 
years (van Buuren et al., 2012); thus, menstrual zinc losses have been taken into account for the 11- to 
14-year-old group of girls, whereas zinc losses in semen have been assumed for boys from 15 years of 
age and older. 
6.2.1.4. Zinc requirement for growth 
For the estimation of zinc requirement for tissue gain, a figure of 30 µg/g of new tissue has previously 
been used for infants and children, whereas, for adolescents, a zinc content of 23 µg/g wet weight has 
been assumed due to an increase in fat tissue with a lower zinc content than that in younger children 
(WHO, 1996). Analyses of whole fetuses of various gestational ages have shown a constant zinc 
content of about 20 µg/g of fat-free tissue (Widdowson and Spray, 1951), and this value has also been 
used in factorial estimates (IOM, 2001). The Panel considers that, in the absence of direct and precise 
data on body composition of infants and children at various postnatal ages, a figure of 20 µg zinc/g 
tissue gained appears to be a reasonable estimate. This value was multiplied with daily weight gains of 
the age groups. Daily weight gains of infants in the second half-year of life were assumed to be 
11.5 g/day, based on observed weight increments of infants in the Euro-Growth Study, where median 
weight gain of boys and girls was 13 g/day from month 6 to 9 and 10 g/day from month 9 to 12 of age 
(van't Hof et al., 2000). For children, daily weight gains were calculated by subtracting the median 
weight at the lower boundary of the age group from that at the higher boundary of the age group and 
dividing this by the number of days in that age interval, assuming that one year equals 365 days. 
6.2.1.5. Fractional absorption of zinc 
The IOM (2001) used a figure of 0.30 for the FAZ for older infants and children based on the literature 
available at that time. The Panel considers that subsequent data (Manary et al., 2000; Griffin et al., 
2004; Lopez de Romana et al., 2005; Mazariegos et al., 2006; Sheng et al., 2006; Griffin et al., 2007) 
provide no reason to modify this figure. As this figure is based on mixed diets that probably contain 
variable quantities of phytate, no adjustment for phytate intake has been made. 
6.2.2. Infants aged 7 to 11 months 
Using a mean weight-for-age of 8.6 kg for boys and girls aged nine months at the 50th percentile 
(WHO Multicentre Growth Reference Study Group, 2006), endogenous faecal zinc losses were 
estimated as 0.343 mg/day (see Section 6.2.1.2) and urine losses were estimated as 0.054 mg/day, 
extrapolated from adult values (see Section 6.2.1.1). No data are available on integumental zinc losses 
in infants which have, therefore, been extrapolated from integumental losses in adults, as described in 
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Section 6.2.1.1, giving a figure of 0.105 mg/day. Estimated total endogenous zinc losses are 
0.502 mg/day. 
Based on an average weight gain of 11.5 g/day for infants in the second half-year of life, the estimated 
zinc requirement for growth is 0.230 mg/day. 
Therefore, the estimated physiological zinc requirement for infants aged 7 to 11 months is 
0.732 mg/day. 
Assuming a FAZ of 0.3 (see Section 6.2.1.5), the AR for infants aged 7 to 11 months is 2.4 mg/day. 
Owing to the absence of reference body weights for infants at the 97.5th percentile, and with no 
knowledge about the variation in requirement, the PRI for infants was estimated based on a CV of 
10 %, and is 2.9 mg/day. 
6.2.3. Children 
Components that were considered for the factorial approach for the various age groups are listed in 
Table 11. The number of digits used for the calculations has been retained in the table, with the 
exception of the AR, for which an erroneous impression of accuracy would be given. 
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Table 11:  Estimates used in the factorial approach to derive the Average Requirements for zinc for children  
Age Reference 
weight 
Zinc losses (mg/day) (a) 
via 
Estimated daily 
weight gain (g/day) (b)
Zinc need for 
growth 
(mg/day) 
Physiological 
requirement 
(mg/day) (c) 
Average 
Requirement 
(mg/day) (d) (kg) Faeces Urine Sweat Semen Menses 
1–3 years 11.9 (e) 0.738 0.075 0.130 – – 6.57 0.131 1.074 3.6 
4–6 years 19.0 (f) 0.965 0.120 0.178 – – 6.35 0.127 1.390 4.6 
7–10 years 28.7 (g) 1.275 0.181 0.236 – – 8.82 0.176 1.869 6.2 
11–14 years (M) 44.0 (h) 1.762 0.278 0.314 – – 14.1 0.282 2.635 8.8 
11–14 years (F) 45.1 (i) 1.797 0.285 0.319 – 0.01 12.6 0.252 2.663 8.9 
15–17 years (M) 64.1 (j) 2.401 0.405 0.403 0.1 – 11.7 0.235 3.544 11.8 
15–17 years (F)  56.4 (k) 2.157 0.357 0.370 – 0.01 3.78 0.076 2.969 9.9 
M, males; F, females. 
(a): See Sections 6.2.1.1 and 6.2.1.2. 
(b): See Section 6.2.1.3. 
(c): Sum of losses and need for growth. 
(d): Estimated from the physiological requirement and assuming an absorption efficiency of 30 % from a mixed diet (see Section 6.2.1.5); values were rounded to the nearest 0.1. 
(e): Mean body weight-for-age at 50th percentile of boys and girls aged 24 months (WHO Multicentre Growth Reference Study Group, 2006). 
(f): Mean body weight at 50th percentile of boys and girls aged five years (van Buuren et al., 2012). 
(g): Mean body weight at 50th percentile of boys and girls aged 8.5 years (van Buuren et al., 2012). 
(h): Body weight at 50th percentile of boys aged 12.5 years (van Buuren et al., 2012). 
(i): Body weight at 50th percentile of girls aged 12.5 years (van Buuren et al., 2012). 
(j): Body weight at 50th percentile of boys aged 16 years (van Buuren et al., 2012). 
(k): Body weight at 50th percentile of girls aged 16 years (van Buuren et al., 2012). 
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Due to the absence of reference body weights for infants and children at the 97.5th percentile, and with 
no knowledge about the variation in requirement, PRIs for infants and children were estimated based 
on a CV of 10 %. Table 12 contains estimates on ARs and PRIs for zinc for infants and children. 
Table 12:  Summary of Average Requirements and Population Reference Intakes for zinc for infants 
and children 
Age Average Requirement (mg/day) Population Reference Intake (mg/day) 
7–11 months 2.4 2.9 
1–3 years 3.6 4.3 
4–6 years 4.6 5.5 
7–10 years 6.2 7.4 
11–14 years 8.9 10.7 
15–17 years (M) 11.8 14.2 
15–17 years (F)  9.9 11.9 
M, males; F, females. 
6.3. Pregnancy and lactation 
Despite some evidence of up-regulation of zinc absorption during pregnancy and notably during early 
lactation (see Section 5.3) and evidence from one unpublished study that this may be sufficient to meet 
increased requirements, the Panel considers that data are insufficient to modify estimated additional 
physiological requirements. The most reliable indicators of zinc requirements at present are the 
addition of the estimated daily increment for pregnancy and the quantity of zinc secreted in milk over 
the first six months of lactation, adjusted for re-absorption of zinc owing to redistribution of tissue 
zinc during postnatal re-adaptation to the non-pregnant state. 
The additional requirements for pregnancy and lactation may be calculated by estimating the 
additional physiological requirement for synthesis of new tissue, primarily the conceptus, and for 
replacement of zinc secreted in breast milk (see Section 5.3). 
For pregnancy, an additional physiological requirement of about 0.4 mg/day may be calculated for the 
whole pregnancy (see Section 5.3). This combined estimate probably overestimates the requirement in 
the first half of pregnancy and underestimates the requirement in the second half of pregnancy. It is 
unknown if the trivariate model used to estimate dietary zinc requirements of non-pregnant non-
lactating women is also suitable in pregnancy and lactation, and up-regulation of zinc absorption is 
likely to modify the inhibitory effect of phytate on zinc absorption. Thus, the Panel decided not to use 
the trivariate model to estimate the dietary zinc intake required to meet the additional physiological 
requirement. Instead, the Panel applied a mean FAZ of 0.30 observed in healthy adults (see Appendix 
I) to the physiological requirement of 0.4 mg/day and estimated the additional average dietary zinc 
requirement in pregnancy to be 1.3 mg/day. In the absence of knowledge about the variation in 
requirement, the additional PRI for pregnancy was estimated based on a CV of 10 %, and was 
1.6 mg/day. 
For lactation, the Panel assumed that the mean increases in physiological requirement are 1.5 mg/day 
for the first month, 1.37 mg/day for months 1 to 2 and 0.86 mg/day for months 3 to 6 post partum (see 
Section 5.3). When the average over six months of lactation is calculated, an additional physiological 
requirement of 1.1 mg/day is determined. Assuming that FAZ is increased 1.5-fold in lactation (see 
Section 5.3), and applying a FAZ of 0.45 to the additional physiological requirement of 1.1 mg/day, an 
additional average dietary zinc requirement in lactation of 2.4 mg/day is determined. In the absence of 
knowledge about the variation in requirement, the additional PRI for lactation was estimated based on 
a CV of 10 %, and was 2.9 mg/day. 
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CONCLUSIONS 
The Panel concludes that ARs and PRIs for zinc can be derived for adults based on a two-stage 
factorial approach. The first stage comprised the estimation of physiological requirement, defined as 
the minimum quantity of absorbed zinc necessary to match losses of endogenous zinc, and its 
relationship with body weight. In the second stage, the quantity of dietary zinc available for absorption 
that is necessary to meet the physiological requirement was determined, taking into account the 
inhibitory effect of phytate on zinc absorption. ARs for adults were estimated as the zinc requirement 
at the 50th percentile of reference body weights for men and women in the EU and for levels of phytate 
intake of 300, 600, 900 and 1 200 mg/day, and PRIs for adults were estimated as the zinc requirement 
of individuals with a body weight at the 97.5th percentile for reference body weights for men and 
women, and for the same range of phytate intake. For infants and children, ARs were estimated based 
on factorial calculation of losses and an estimation of the need for growth. For pregnant and lactating 
women, the increase in physiological requirement was estimated based on the demand for new tissue, 
primarily by the conceptus, and on the provision of zinc secreted in breast milk, respectively. ARs 
were derived taking into account the FAZ. In the absence of knowledge about the variation in 
requirement, PRIs for infants and children and PRIs to cover the additional requirement of pregnant 
and lactating women were estimated based on a CV of 10 %. 
Table 13:  Summary of Population Reference Intakes for zinc  
 Level of phytate intake 
(mg/day) 
Population Reference Intake 
(mg/day) 
Age 
7–11 months    2.9 
1–3 years    4.3 
4–6 years    5.5 
7–10 years    7.4 
11–14 years    9.4 
15–17 years (M)  12.5 
15–17 years (F)   10.4 
≥ 18 years (M)    300   9.4 
   600 11.7 
   900 14.0 
1 200 16.3 
≥ 18 years (F)    300   7.5 
   600   9.3 
   900 11.0 
1 200 12.7 
Pregnancy  + 1.6 
Lactation  + 2.9 
M, males; F, females. 
RECOMMENDATIONS FOR RESEARCH 
The Panel suggests that studies of zinc homeostasis in European populations should be undertaken 
using state of the art techniques, and should target the more vulnerable populations such as young 
children, adolescents, pregnant and lactating women and the elderly. 
The Panel recommends that additional reliable data on phytate intake in the EU be collected. 
The Panel recommends that studies be undertaken to identify suitable biomarkers of zinc status and 
also recommends that methods to derive zinc requirements be further refined. 
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APPENDICES 
Appendix A.  Concentrations of zinc in breast milk from mothers of term infants in Europe 
Reference n (number 
of samples) 
Country Maternal dietary 
intake (mg/day) 
mean ± SD 
Stage of lactation Zinc concentration (mg/L) Analytical 
method 
Comments 
Mean ± SD Median Range 
          
Bates and 
Tsuchiya 
(1990) 
57 UK Not reported 2 months post partum 1.34 (a)   AAS Infants assumed 
to be term 
infants on the 
basis of the 
study design 
and setting 
3 months post partum 2.06 (a) 
4 months post partum 0.87 (a) 
5 months post partum 0.73 (a) 
6 months post partum 0.73 (a) 
Bjorklund et al. 
(2012) 
60 Sweden Not reported 14–21 days post partum 3.47 ± 0.98 3.52 1.24–5.71 ICP-MS  
Chierici et al. 
(1999) 
11 Italy Non-supplemented 
women with a 
dietary zinc intake 
of about 12 mg/day 
as estimated by 
three-day dietary 
record 
3 days post partum 8.16 ± 2.96   Inorganic 
mass 
spectrometry
 
30 days post partum 3.99 ± 1.01 
90 days post partum 2.87 ± 1.23 
Supplemented 
women receiving 
20 mg/day of 
supplemental zinc 
3 days post partum 5.89 ± 2.65 
30 days post partum 3.36 ± 1.40 
90 days post partum 2.63 ± 1.35 
Domellof et al. 
(2004) 
86 Sweden Not reported 9 months post partum 0.46 ± 0.26   AAS Dietary intake 
of the mothers 
assessed with a 
five-day food 
diary 
Elmastas et al. 
(2005) 
32 (32) Turkey Not reported 2 months post partum 1.20 ± 0.01   FAAS with 
microwave 
digestion 
 
Kantola and 
Vartiainen 
(2001) 
175 (175) Finland Not reported 4 weeks post partum 3.00 ± 1.00   FAAS with 
microwave 
digestion 
Two analyses 
(in 1987 and in 
1993–1995) 
81 (81) 1.40 ± 0.70 
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Reference n (number 
of samples) 
Country Maternal dietary 
intake (mg/day) 
mean ± SD 
Stage of lactation Zinc concentration (mg/L) Analytical 
method 
Comments 
Mean ± SD Median Range 
          
Leotsinidis et 
al. (2005) 
180 (180) Greece Not reported 3 days post partum 4.91 ± 1.73 5.01 1.32–9.12 FAAS  
95 (95) 17 days post partum 2.99 ± 0.92 2.97 0.86–6.55 
Matos et al. 
(2009) 
31 (155) Portugal Not reported 7 days post partum 4.13 ± 1.22 (a) 4.04 (a) 2.12–6.98 (a) ICP-MS  
4 weeks post partum 2.22 ± 0.61 (a) 2.10 (a) 1.26–3.77 (a) 
8 weeks post partum 1.53 ± 0.64 (a) 1.46 (a) 0.33–3.05 (a) 
12 weeks post partum 1.11 ± 0.56 (a) 1.10 (a) 0.22–2.27 (a) 
16 weeks post partum 1.04 ± 0.47 (a) 1.00 (a) 0.15–2.29 (a) 
Ortega et al. 
(1997) 
25 Spain Women with zinc 
intake < 50 % RI (b) 
from diet and 
supplements 
assessed during the 
third trimester of 
pregnancy: 
8.3 ± 1.0 
13–14 days post partum 3.03 ± 0.47   Not reported Maternal intake 
assessed with 
five-day dietary 
record  
40 days post partum 1.86 ± 0.40 
Women with zinc 
intake > 50 % RI (b) 
from diet and 
supplements 
assessed during the 
third trimester of 
pregnancy: 
12.3 ± 1.9 
13–14 days post partum 3.31 ± 0.60 
40 days post partum 2.15 ± 0.52 
Perrone et al. 
(1993); 
Perrone et al. 
(1994) 
(46) Italy Not reported 1 week post partum  36.4 ± 2.8 (c, d)  Not reported  
(15) 2 weeks post partum 24.2 ± 1.6 (c, d) 
(19) 3 weeks post partum 28.6 ± 6.8 (c, d) 
(59) > 3 weeks post partum 21.7 ± 1.4 (c, d) 
Piotrowska-
Dept et al. 
(2006) 
27 Poland 10.7 ± 3.3 (range 
5.7–18.2) 
0–30 days post partum 3.42 ± 1.62 3.29 0.53–7.28 AAS Dietary zinc 
intake of the 
mothers 
assessed by a 
24-hour record 
18 31–90 days post partum 1.50 ± 0.87 1.37 0.12–3.58 
8 > 90 days post partum 0.86 ± 0.57 0.64 0.28–1.51 
Rodriguez 
Rodriguez et 
al. (2000) 
11 (56) Spain Not reported 2 weeks to 5 months 
post partum 
2.10 ± 1.10  0.14–3.99 AAS   
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Reference n (number 
of samples) 
Country Maternal dietary 
intake (mg/day) 
mean ± SD 
Stage of lactation Zinc concentration (mg/L) Analytical 
method 
Comments 
Mean ± SD Median Range 
Salmenpera et 
al. (1994) 
75 Finland Non- supplemented 
women 
4–5 days post partum  4.75 3.27–6.9   
77 2 months post partum 1.41 1.1–2.19 
67 4 months post partum 0.9 0.58–1.38 
56 6 months post partum 0.67 0.4–1.13 
31 7.5 months post partum 0.61 0.39–0.97 
14 9 months post partum 0.6 0.38–0.95 
8 10 months post partum 0.61 0.42–0.87 
6 11 months post partum 0.43 0.33–0.57 
5 12 months post partum 0.43 0.33–0.56 
62 Supplemented 
women (20 mg/day)
4–5 days post partum 4.94 3.50–6.98 
58 2 months post partum 1.52 1.10–2.11 
48 4 months post partum 0.95 0.65–1.39 
38 6 months post partum 0.67 0.43–1.03 
26 7.5 months post partum 0.63 0.43–0.92 
16 9 months post partum 0.6 0.41–0.88 
4 10 months post partum 0.41 0.36–0.48 
5 11 months post partum 0.51 0.44–0.60 
2 12 months post partum 0.46 0.26–0.79 
22 Supplemented 
women (40 mg/day)
4–5 days post partum 5.18 3.33–8.04 
24 2 months post partum 1.38 0.70–2.73 
15 4 months post partum 1.08 0.61–1.94 
13 6 months post partum 0.88 0.50–1.53 
5 7.5 months post partum 0.9 0.62–1.30 
4 9 months post partum 0.94 0.71–1.24 
Sievers et al. 
(1992) 
10 Germany Not reported 17 days post partum  3.6  AAS  
35 days post partum 2.6 
56 days post partum 1.7 
85 days post partum 1.3 
117 days post partum 1.2 
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Reference n (number 
of samples) 
Country Maternal dietary 
intake (mg/day) 
mean ± SD 
Stage of lactation Zinc concentration (mg/L) Analytical 
method 
Comments 
Mean ± SD Median Range 
Silvestre et al. 
(2000a) 
(10) Spain Not reported Colostrum (number of 
days not reported) 
8.60 ± 1.82   FAAS with 
microwave 
digestion 
 
Transitional milk 
(number of days not 
reported) 
3.45 ± 0.58 
30 days post partum 1.97 ± 0.25 
60 days post partum 1.24 ± 0.33 
90 days post partum  0.89 ± 0.27 
Silvestre et al. 
(2000b) 
62 (136) Spain Not reported 2 days post partum 7.73 ± 0.86   FAAS with 
microwave 
digestion 
 
15 days post partum 3.15 ± 0.86 
Silvestre et al. 
(2001) 
22 (110) Spain Not reported Colostrum (number of 
days not reported) 
7.99 ± 3.23   FAAS  
Transitional milk 
(number of days not 
reported) 
3.31 ± 1.06 
30 days post partum 2.41 ± 0.90 
60 days post partum 1.40 ± 0.65 
90 days post partum  1.05 ± 0.71 
Stawarz et al. 
(2007) 
5 (210) Poland Not reported 12 weeks 17.94 ± 7.10 (c)  4.42–38.61 Volumetric 
method 
 
Ustundag et al. 
(2005) 
20 Turkey Not reported Colostrum (0–7 days 
post partum) 
3.08 ± 0.30   AAS   
7–14 days post partum 2.72 ± 0.20 
21 days post partum 2.65 ± 0.20 
60 days post partum 2.81 ± 0.18 
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Reference n (number 
of samples) 
Country Maternal dietary 
intake (mg/day) 
mean ± SD 
Stage of lactation Zinc concentration (mg/L) Analytical 
method 
Comments 
Mean ± SD Median Range 
Vuori et al. 
(1980) 
15 (15) Finland 
 
  
13.7 ± 2.7 6–8 weeks post partum 1.89 ± 0.74   FAAS  Two seven-day 
food records; 
infants assumed 
to be term 
infants on the 
basis of the 
study design 
and setting 
 12.8 ± 2.8 17–22 weeks post 
partum 
0.72 ± 0.44 
 
Wasowicz et 
al. (2001) 
43 Poland  Not reported 0–4 days post partum 8.2 ± 2.8   ICP-AES  
46 5–9 days post partum 3.7 ± 1.8 
41 10–30 days post partum 1.4 ± 0.7 
Yalcin et al. 
(2009) 
47 Turkey Not reported 2 weeks post partum 4.78 ± 1.83 4.5  AAS  
Studies were identified by a comprehensive literature search for publications from the year 2000 onwards, earlier publications were identified from Brown et al. (2009). The following articles 
based on one or two case reports are not presented in this table: Sievers and Schaub (2004), Kharfi et al. (2005), Chowanadisai et al. (2006), Coelho et al. (2006), Mandato et al. (2009); Milacic 
et al. (2012), Leverkus et al. (2006); Gass et al. (2010); Bieri et al. (2013); Miletta et al. (2013). 
AAS, atomic absorption spectrometry; ICP-MS, inductively coupled plasma mass spectrometry; FAAS, flame atomic absorption spectrometry; RI, recommended intake; ICP-AES, inductively 
coupled plasma atomic emission spectroscopy. 
(a): After conversion from mg/g into mg/L using a conversion factor of 1.03 kg/L of breast milk, as reported in Brown et al. (2009). 
(b): Value not reported. 
(c): mg/kg dry weight of breast milk. 
(d): Median ± SD 
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Appendix B.  Dietary surveys in the EFSA Comprehensive database update dataset included in the nutrient intake calculation and number of 
subjects in the different age classes 
y, years; DIPP, type 1 Diabetes Prediction and Prevention survey; DNFCS, Dutch National Food Consumption Survey; EsKiMo, Ernährungstudie als KIGGS-Modul; FINDIET, the national 
dietary survey of Finland; INCA, étude Individuelle Nationale de Consommations Alimentaires; INRAN-SCAI, Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione - Studio sui 
Consumi Alimentari in Italia; FC_PREGNANTWOMEN, food consumption of pregnant women in Latvia; NANS, National Adult Nutrition Survey; NDNS, National Diet and Nutrition Survey; 
NWSSP, Nutrition and Wellbeing of Secondary School Pupils; VELS, Verzehrsstudie zur Ermittlung der Lebensmittelaufnahme von Säuglingen und Kleinkindern für die Abschätzung eines 
akuten Toxizitätsrisikos durch Rückstände von Pflanzenschutzmitteln. 
(a): A 48-hour dietary recall comprises two consecutive days. 
(b): 5th or 95th percentile of intake calculated over a number of subjects lower than 60 require cautious interpretation as the results may not be statistically robust (EFSA, 2011b) and therefore for 
these dietary surveys/age classes the 5th, 95th percentile estimates will not be presented in the intake results. 
(c): One subject was excluded from the dataset because only one 24-hour dietary recall day was available, i.e. final n = 990. 
(d): The Swedish dietary records were introduced through the internet. 
Country Dietary survey Year Method Days Age 
(years) 
Number of subjects 
Children 
1 to < 3 y 
Children 
3 to < 10 y 
Adolescents
10 to < 18 y
Adults 
18 to < 65 y 
Adults 
65 to < 75 y
Adults 
≥ 75 y 
Finland/1 DIPP  2000–2010 Dietary record  3 < 1–6 500 750     
Finland/2 NWSSP 2007–2008 48-hour dietary 
recall (a) 
2 x 2 (a) 13–15   306    
Finland/3 FINDIET2012 2012 48-hour dietary 
recall (a) 
2 (a) 25–74    1 295 413  
France INCA2 2006–2007 Dietary record 7 3–79  482 973 2 276 264 84 
Germany/1 EsKiMo 2006 Dietary record 3 6–11  835 393    
Germany/2 VELS  2001–2002 Dietary record 6 < 1–4 347 299     
Ireland NANS 2008–2010 Dietary record  4 18–90    1 274 149 77 
Italy INRAN-SCAI 2005–06 2005–2006 Dietary record  3 < 1–98 36 (b) 193 247 2 313 290 228 
Latvia FC_PREGNANTWOM
EN 2011 
2011 24-hour dietary 
recall 
2 15–45   12 (b) 991  (c)   
Netherlands DNFCS 2007–2010 24-hour dietary 
recall  
2 7–69  447 1 142 2 057 173  
Sweden RISKMATEN 2010–2011 Dietary record 
(Web) (d) 
4 18–80    1 430 295 72 
UK NDNS—Rolling 
Programme (1–3 years) 
2008–2011 Dietary record  4 1–94 185 651 666 1 266 166 139 
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Appendix C.  Zinc intake in males in different surveys according to age classes and country 
Age class (years) Country Survey Intake expressed in mg/day Intake expressed in mg/MJ 
n (a) Average Median P5 P95 n (a) Average Median P5 P95 
1 to < 3  Finland DIPP_2001_2009 245 5.5 5.4 3.2 8.4 245 1.5 1.5 1.1 2.0 
Germany VELS 174 5.0 4.8 2.9 7.3 174 1.1 1.0 0.7 1.4 
Italy INRAN_SCAI_2005_06 20 6.2 6.3 (b) (b) 20 1.3 1.3 (b) (b) 
UK NDNS–RollingProgrammeYears1–3 107 5.8 5.6 3.6 9.0 107 1.2 1.2 0.8 1.6 
3 to < 10  Finland DIPP_2001_2009 381 8.5 8.4 5.3 12.1 381 1.4 1.4 1.1 1.9 
 France INCA2 239 8.8 8.5 4.9 12.9 239 1.4 1.4 0.9 2.0 
 Germany EsKiMo 426 9.3 9.0 5.9 13.1 426 1.2 1.2 0.9 1.6 
 Germany VELS 146 6.1 5.8 3.9 8.7 146 1.1 1.0 0.8 1.4 
 Italy INRAN_SCAI_2005_06 94 9.3 8.9 5.3 13.9 94 1.3 1.3 0.9 1.8 
 Netherlands DNFCS2007_2010 231 8.0 7.7 4.6 12.6 231 0.9 0.9 0.6 1.3 
 UK NDNS–RollingProgrammeYears1–3 326 6.7 6.6 3.9 10.3 326 1.1 1.0 0.7 1.5 
10 to < 18  Finland NWSSP07_08 136 12.2 11.9 7.5 17.5 136 1.5 1.5 1.1 1.9 
 France INCA2 449 10.7 10.3 6.0 16.9 449 1.4 1.3 0.9 2.0 
 Germany EsKiMo 197 10.0 9.6 6.3 14.9 197 1.2 1.2 0.9 1.6 
 Italy INRAN_SCAI_2005_06 108 12.2 11.4 7.2 18.0 108 1.3 1.2 0.9 1.7 
 Netherlands DNFCS2007_2010 566 10.2 9.8 5.6 16.5 566 1.0 0.9 0.6 1.4 
 UK NDNS–RollingProgrammeYears1–3 340 8.7 8.4 4.9 13.5 340 1.1 1.0 0.7 1.6 
18 to < 65  Finland FINDIET2012 585 12.7 12.2 6.6 20.7 585 1.4 1.3 0.9 2.0 
 France INCA2 936 11.6 11.4 6.3 18.2 936 1.3 1.3 0.9 2.0 
 Ireland NANS_2012 634 12.2 11.9 7.0 18.8 634 1.2 1.2 0.8 1.8 
 Italy INRAN_SCAI_2005_06 1 068 11.3 11.0 6.6 17.0 1 068 1.3 1.2 0.9 1.7 
 Netherlands DNFCS2007_2010 1 023 12.0 11.6 6.6 18.9 1 023 1.1 1.0 0.7 1.5 
 Sweden Riksmaten 2010 623 13.7 13.2 7.4 21.7 623 1.4 1.4 1.0 2.0 
 UK NDNS–RollingProgrammeYears1–3 560 9.9 9.5 5.3 15.9 560 1.1 1.1 0.7 1.7 
65 to < 75  Finland FINDIET2012 210 10.8 10.4 5.9 17.0 210 1.3 1.3 0.9 2.0 
 France INCA2 111 11.0 10.4 6.4 16.8 111 1.3 1.2 0.9 1.8 
 Ireland NANS_2012 72 11.3 11.2 5.5 17.0 72 1.3 1.2 0.9 2.1 
 Italy INRAN_SCAI_2005_06 133 11.2 10.8 6.8 16.3 133 1.3 1.3 0.9 1.7 
 Netherlands DNFCS2007_2010 91 11.1 10.6 5.9 17.0 91 1.2 1.2 0.8 1.7 
 Sweden Riksmaten 2010 127 12.0 11.0 7.4 19.3 127 1.4 1.3 1.0 2.0 
 UK NDNS–RollingProgrammeYears1–3 75 10.0 9.8 3.7 16.5 75 1.2 1.2 0.7 1.8 
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Age class (years) Country Survey Intake expressed in mg/day Intake expressed in mg/MJ 
n (a) Average Median P5 P95 n (a) Average Median P5 P95 
≥ 75  France INCA2 40 9.9 9.4 (b) (b) 40 1.3 1.3 (b) (b) 
 Ireland NANS_2012 34 10.0 9.5 (b) (b) 34 1.3 1.2 (b) (b) 
 Italy INRAN_SCAI_2005_06 69 10.6 10.3 6.9 15.0 69 1.2 1.2 1.0 1.7 
 Sweden Riksmaten 2010 42 11.0 10.9 (b) (b) 42 1.3 1.2 (b) (b) 
 UK NDNS–RollingProgrammeYears1–3 56 8.4 8.0 (b) (b) 56 1.2 1.1 (b) (b) 
P5, 5th percentile; P95, 95th percentile; DIPP, type 1 Diabetes Prediction and Prevention survey; DNFCS, Dutch National Food Consumption Survey; EsKiMo, Ernährungstudie als KIGGS-
Modul; FINDIET, the national dietary survey of Finland; INCA, étude Individuelle Nationale de Consommations Alimentaires; INRAN-SCAI, Istituto Nazionale di Ricerca per gli Alimenti 
e la Nutrizione - Studio sui Consumi Alimentari in Italia; FC_PREGNANTWOMEN, food consumption of pregnant women in Latvia; NANS, National Adult Nutrition Survey; NDNS, 
National Diet and Nutrition Survey; NWSSP, Nutrition and Wellbeing of Secondary School Pupils; VELS, Verzehrsstudie zur Ermittlung der Lebensmittelaufnahme von Säuglingen und 
Kleinkindern für die Abschätzung eines akuten Toxizitätsrisikos durch Rückstände von Pflanzenschutzmitteln. 
(a): Number of individuals in the population group. 
(b): 5th or 95th percentile of intake calculated from less than 60 subjects requires cautious interpretation, as the results may not be statistically robust (EFSA, 2011b) and, therefore, for these 
dietary surveys/age classes, the 5th and 95th percentile estimates will not be presented in the intake results. 
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Appendix D.  Zinc intake in females in different surveys according to age classes and country 
Age class (years) Country Survey Intake expressed in mg/day Intake expressed in mg/MJ 
n (a) Average Median P5 P95 n (a) Average Median P5 P95 
1 to < 3  Finland DIPP_2001_2009 255 5.3 5.0 2.9 8.3 255 1.5 1.5 1.1 2.0 
 Germany VELS 174 4.6 4.6 2.8 6.7 174 1.1 1.1 0.8 1.4 
 Italy INRAN_SCAI_2005_06 16 5.8 6.1 (b) (b) 16 1.3 1.1 (b) (b) 
 UK NDNS–RollingProgrammeYears1–3 78 5.3 5.3 3.1 7.8 78 1.2 1.2 0.9 1.5 
3 to < 10  Finland DIPP_2001_2009 369 7.7 7.6 5.3 10.9 369 1.5 1.4 1.1 1.9 
 France INCA2 243 7.9 7.8 5.0 12.4 243 1.4 1.4 0.9 2.1 
 Germany EsKiMo 409 8.4 8.1 5.5 12.4 409 1.2 1.2 0.9 1.7 
 Germany VELS 147 5.5 5.3 3.5 8.4 147 1.1 1.0 0.7 1.5 
 Italy INRAN_SCAI_2005_06 99 8.9 8.5 5.0 13.1 99 1.2 1.2 0.9 1.7 
 Netherlands DNFCS2007_2010 216 7.5 7.3 4.3 11.7 216 0.9 0.9 0.5 1.4 
 UK NDNS–RollingProgrammeYears1–3 325 6.4 6.3 3.7 9.6 325 1.1 1.0 0.7 1.5 
10 to < 18  Finland NWSSP07_08 170 9.7 9.5 5.7 15.0 170 1.5 1.5 1.1 1.9 
 France INCA2 524 8.4 8.2 4.7 12.9 524 1.3 1.3 0.9 2.0 
 Germany EsKiMo 196 9.3 9.0 6.0 13.5 196 1.2 1.2 0.9 1.7 
 Italy INRAN_SCAI_2005_06 139 9.8 9.6 5.8 14.4 139 1.2 1.2 0.9 1.6 
 Latvia FC_PREGNANTWOMEN_2011 (c) 12 14.5 13.2 (b) (b) 12 1.5 1.5 (b) (b) 
 Netherlands DNFCS2007_2010 576 8.4 8.2 4.9 12.5 576 1.0 0.9 0.6 1.4 
 UK NDNS–RollingProgrammeYears1–3 326 6.8 6.7 3.4 10.6 326 1.0 1.0 0.6 1.5 
18 to < 65  Finland FINDIET2012 710 9.8 9.5 5.2 15.5 710 1.4 1.3 0.9 2.0 
 France INCA2 1340 8.9 8.6 4.7 14.0 1340 1.4 1.3 0.9 2.2 
 Ireland NANS_2012 640 9.0 8.8 5.0 13.8 640 1.2 1.2 0.8 1.8 
 Italy INRAN_SCAI_2005_06 1245 9.4 9.2 5.4 13.8 1245 1.3 1.2 0.9 1.8 
 Latvia FC_PREGNANTWOMEN_2011 (c) 990 14.0 13.3 7.9 22.8 990 1.7 1.6 1.0 2.6 
 Netherlands DNFCS2007_2010 1034 9.5 9.0 5.3 15.0 1034 1.2 1.1 0.7 1.8 
 Sweden Riksmaten 2010 807 10.5 10.1 5.8 16.6 807 1.4 1.3 1.0 2.0 
 UK NDNS–RollingProgrammeYears1–3 706 8.0 7.8 4.2 12.3 706 1.2 1.2 0.7 1.8 
65 to < 75  Finland FINDIET2012 203 8.5 8.3 4.5 13.2 203 1.4 1.4 0.9 1.9 
 France INCA2 153 8.6 8.0 4.5 13.7 153 1.4 1.3 0.9 2.2 
 Ireland NANS_2012 77 9.9 9.7 5.0 14.7 77 1.5 1.4 1.0 2.1 
 Italy INRAN_SCAI_2005_06 157 9.1 8.9 4.7 14.5 157 1.3 1.3 0.9 1.9 
 Netherlands DNFCS2007_2010 82 8.7 8.6 4.2 13.5 82 1.2 1.2 0.7 1.7 
 Sweden Riksmaten 2010 168 9.6 9.3 5.1 14.8 168 1.4 1.3 1.0 1.9 
 UK NDNS–RollingProgrammeYears1–3 91 8.1 8.0 5.2 11.8 91 1.4 1.3 0.9 1.9 
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Age class (years) Country Survey Intake expressed in mg/day Intake expressed in mg/MJ 
n (a) Average Median P5 P95 n (a) Average Median P5 P95 
≥ 75  France INCA2 44 8.0 7.3 (b) (b) 44 1.3 1.3 (b) (b) 
 Ireland NANS_2012 43 9.1 9.2 (b) (b) 43 1.5 1.4 (b) (b) 
 Italy INRAN_SCAI_2005_06 159 8.6 8.4 5.1 12.4 159 1.3 1.3 0.9 1.8 
 Sweden Riksmaten 2010 30 9.3 9.4 (b) (b) 30 1.3 1.3 (b) (b) 
 UK NDNS–RollingProgrammeYears1–3 83 8.2 7.8 4.9 12.3 83 1.4 1.3 0.9 1.9 
P5, 5th percentile; P95, 95th percentile; DIPP, type 1 Diabetes Prediction and Prevention survey; DNFCS, Dutch National Food Consumption Survey; EsKiMo, Ernährungstudie als KIGGS-
Modul; FINDIET, the national dietary survey of Finland; INCA, étude Individuelle Nationale de Consommations Alimentaires; INRAN-SCAI, Istituto Nazionale di Ricerca per gli Alimenti 
e la Nutrizione - Studio sui Consumi Alimentari in Italia; FC_PREGNANTWOMEN, food consumption of pregnant women in Latvia; NANS, National Adult Nutrition Survey; NDNS, 
National Diet and Nutrition Survey; NWSSP, Nutrition and Wellbeing of Secondary School Pupils; VELS, Verzehrsstudie zur Ermittlung der Lebensmittelaufnahme von Säuglingen und 
Kleinkindern für die Abschätzung eines akuten Toxizitätsrisikos durch Rückstände von Pflanzenschutzmitteln. 
(a): Number of individuals in the population group.  
(b): 5th or 95th percentile of intake calculated from less than 60 subjects requires cautious interpretation, as the results may not be statistically robust (EFSA, 2011b) and, therefore, for these 
dietary surveys/age classes, the 5th and 95th percentile estimates will not be presented in the intake results. 
(c): Pregnant women only. 
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Appendix E.  Minimum and maximum percentage contribution of different FoodEx2 level 1 food groups to zinc intake in males 
Food groups Age (years) 
1 to < 3 3 to < 10 10 to < 18 18 to < 65 65 to < 75 ≥ 75 
Additives, flavours, baking and processing aids < 0.1–0.2 0–0.7 < 0.1–1.1 < 0.1–0.2 0–0.1 0 
Alcoholic beverages < 0.1 < 0.1 < 0.1–0.1 0.7–1.6 0.7–2.2 0.3–2.2 
Animal and vegetable fats and oils 0.1–0.3 0.1–0.3 0.1–0.3 0.1–0.3 0.1–0.4 0.1–0.4 
Coffee, cocoa, tea and infusions < 0.1–2.2 1–4.1 1.5–2.9 0.9–4.6 0.9–7.1 0.7–7.9 
Composite dishes 0.6–12.8 0.1–15.8 0.3–23 0.4–18.6 0.5–12.5 0.2–12.8 
Eggs and egg products 0.5–2 0.1–3.4 0.1–3.3 < 0.1–2.6 < 0.1–2.6 0.1–2.4 
Fish, seafood, amphibians, reptiles and invertebrates 0.2–7.2 0.2–6.5 0.3–6 0.7–6.4 1.1–7.4 2.1–5.4 
Food products for young population 3–15.6 0.2–0.8 < 0.1–0.1 < 0.1 – – 
Fruit and fruit products 1.6–3.2 1.3–6.6 0.8–2.2 0.9–2 1.2–3 1.5–5.3 
Fruit and vegetable juices and nectars 0.5–1.9 0.3–2.3 0.3–2.1 0.2–1.4 0.1–1.4 0.1–0.7 
Grains and grain-based products 18.8–31.7 18.1–35.4 20–36 18.5–28.9 18.7–31.5 18.9–34.5 
Human milk < 0.1–1.7 – – – – – 
Legumes, nuts, oilseeds and spices 1.1–3 1.2–4 1.1–3.2 1.6–4 1.8–4.4 1.3–2.9 
Meat and meat products 9.8–24.1 13.2–36.7 19.7–44.5 22.4–45.8 20.5–40.8 20.1–38.8 
Milk and dairy products 27.2–34.2 19.1–34.4 13.4–31.1 12.1–23.9 11.6–24.8 13–20.4 
Products for non-standard diets, food imitates and food 
supplements or fortifying agents 
0–0.2 0–1.1 < 0.1–0.6 < 0.1–1 < 0.1–0.6 0–0.2 
Seasoning, sauces and condiments 0.1–0.7 0.1–0.6 0.1–0.6 0.2–0.9 0.2–0.8 0.2–0.8 
Starchy roots or tubers and products thereof, sugar plants 1–2.4 0.7–4.9 0.7–5.9 1.2–5.1 1.2–5.1 1.2–5.6 
Sugar, confectionery and water-based sweet desserts 0.2–2.7 0.4–4.3 0.4–4.2 0.3–1 0.2–0.6 0.1–0.7 
Vegetables and vegetable products 2–6.5 2.1–7 2–6.8 1.5–8.8 1.7–9.8 2.1–9.8 
Water and water-based beverages 0.5–1.7 0.5–1.6 0.6–2.1 0.6–1.6 0.4–1.5 0.3–1.5 
“–” means that there was no consumption event of the food group for the age and sex group considered, whereas “0” means that there were some consumption events, but that the food group 
does not contribute to the intake of the nutrient considered, for the age and sex group considered. 
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Appendix F.  Minimum and maximum percentage contribution of different FoodEx2 level 1 food groups to zinc intake in females 
Food groups Age (years) 
1 to < 3 3 to < 10 10 to < 18 18 to < 65 65 to < 75 ≥ 75 
Additives, flavours, baking and processing aids 0–0.2 0–0.7 < 0.1–1.1 < 0.1–0.2 < 0.1–0.1 0 
Alcoholic beverages < 0.1 < 0.1 < 0.1–0.1 < 0.1–0.8 0.1–1 0.2–0.9 
Animal and vegetable fats and oils 0.1–0.3 0.1–0.3 0.1–0.3 0.1–0.3 0.1–0.4 0.1–0.4 
Coffee, cocoa, tea and infusions < 0.1–2.6 0.8–4.4 1.6–4.5 1.2–7.1 1–9.3 1.4–9.5 
Composite dishes 0.2–11.7 0.1–15.9 0.5–23.7 0.5–15 0.3–13.2 0.5–12.2 
Eggs and egg products 0.4–2.2 0.1–3.3 0.1–3.3 0.1–2.4 0.1–2.3 0.1–2.7 
Fish, seafood, amphibians, reptiles and invertebrates 0.1–8.6 0.2–5.2 0.3–7.3 0.6–7 0.9–6.9 1–4.7 
Food products for young population 3.1–13 < 0.1–0.4 < 0.1–0.1 < 0.1 – < 0.1 
Fruit and fruit products 1.1–2.7 1.2–8.1 1.2–6 1.2–4.7 2.6–8.7 2–4.9 
Fruit and vegetable juices and nectars 0.3–1.7 0.4–2.2 0.4–2 0.2–1.3 0.2–1.3 0.2–1.1 
Grains and grain-based products 19.6–31.1 16.9–36.8 20.2–35.8 17.4–39.7 16.3–31.7 15.5–33.4 
Human milk < 0.1 – – – – – 
Legumes, nuts, oilseeds and spices 1–3.1 1.2–3.8 1.1–3.2 1.6–4.5 1.5–3.8 1–3.1 
Meat and meat products 10.9–22.3 13.5–35.9 17.4–41.3 19.4–40 18.2–36.4 16–37.4 
Milk and dairy products 27.2–30.9 19.4–36.3 13.2–30.3 13.2–26.5 13.8–26.5 14.4–24.1 
Products for non-standard diets, food imitates and food 
supplements or fortifying agents 
0–0.7 0–1.4 < 0.1–1 0.1–3.4 0.1–1.7 0–1.7 
Seasoning, sauces and condiments 0.1–0.5 0.1–0.6 0.1–0.9 0.2–1 0.2–0.7 0.2–0.9 
Starchy roots or tubers and products thereof, sugar plants 1.1–3.5 0.6–5.2 0.6–5.6 1–4.8 1.1–4.5 1.3–4.1 
Sugar, confectionery and water-based sweet desserts 0.2–2.5 0.6–4.2 0.5–4.3 0.3–2.4 0.2–0.8 0.2–0.9 
Vegetables and vegetable products 2–5.4 2.3–7.2 1.9–6.8 2.2–10.1 2.4–11.2 2.8–10.1 
Water and water-based beverages 0.5–1.5 0.5–1.7 0.2–1.9 0.2–2.1 0.5–1.9 0.4–2.5 
“–” means that there was no consumption event of the food group for the age and sex group considered, whereas “0” means that there were some consumption events, but that the food group 
does not contribute to the intake of the nutrient considered, for the age and sex group considered. 
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Appendix G.  Phytate/Phytic acid intake in various European countries 
Study Country Sex (n) Age (years) Phytic acid/phytate intake (mg/day) Phytate–zinc molar 
ratio median (IQR)
Comments/methods of assessment 
Mean ± SD or 
(range) 
Median (IQR) 
Adults 
Amirabdollahian 
and Ash (2010) 
UK Male (108) 19–24 817 762 (565–940) 8.21 (6.82–10.30) Phytate intake was assessed based on food 
consumption data obtained in the National 
Diet and Nutrition Survey and the content 
of phytate in food according to published 
and unpublished data (the phytate content 
of food in the UK is unavailable) 
Male (219) 25–34 1 010 904 (659–1 132) 9.11 (7.31–11.47) 
Male (253) 35–49 993 903 (670–1 262) 8.80 (6.58–11.65) 
Male (253) 50–64 1 094 948 (679–1 314) 9.27 (7.24–12.23) 
Male (371) 65–74 891 733 (509–1 112) 8.70 (6.26–11.50) 
Male (200) 75–84 938 692 (453–1 145) 8.78 (6.32–12.58) 
Male (62) > 85 1 059 779 (496–1 419) 8.97 (7.13–17.94) 
Female (104) 19–24 650 645 (438–790) 9.28 (7.00–12.11) The authors acknowledged that those data 
may be inaccurate owing to the use of non-
peer-reviewed food composition data, the 
unavailability of data on the phytate 
content for many foods and the accuracy of 
the method to measure phytate 
Female (210) 25–34 756 714 (486–910) 10.50 (8.20–13.23) 
Female (318) 35–49 868 792 (568–1 071) 10.27 (8.00–14.03) 
Female (259) 50–64 928 807 (599–1 138) 10.51 (8.26–13.82) 
Female (434) 65–74 693 630 (426–849) 8.93 (6.43–11.26) 
Female (638) 75–84 674 549 (392–777) 8.50 (6.25–10.91) 
Female (251) > 85 712 538 (416–772) 8.40 (6.90–11.62) 
Prynne et al. 
(2010) 
UK Male (562) 36 662 (626–698) (a)  5.7 (5.5–6.0) (a) Dietary survey following the same 
individuals over several years (follow-up 
dietary survey) 
43 666 (634–698) (a) 5.9 (5.6–6.1) (a) 
53 715 (684–747) (a) 6.8 (6.5–7.0) (a) 
Female (691) 36 566 (536–597) (a) 6.3 (6.0–6.6) (a) Phytate intake was assessed based on food 
consumption data obtained by five-day 
dietary records and the phytate content of 
foods. The original (British) nutrient 
composition database was updated with 
phytate data for US foods for principal 
sources of phytate 
43 562 (537–587) (a) 6.3 (6.1–6.5) (a) 
53 647 (622–671) (a) 7.5 (7.3–7.8) (a) 
Heath et al. (2005) UK Male (49) > 40 MBIAT: 
1 436 ± 755 
1 328 (918–
1 876) 
11.64 (8.24–15.07) Phytate intake was assessed by 
MBIAT/WDR and food composition data 
based on published articles WDR: 1 366 ± 559 1 374 (855–
1 707) 
11.03 (8.62–14.64) 
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Study Country Sex (n) Age (years) Phytic acid/phytate intake (mg/day) Phytate–zinc molar 
ratio median (IQR)
Comments/methods of assessment 
Mean ± SD or 
(range) 
Median (IQR) 
Brune et al. (1989) Sweden Male + female 
(6) 
24–70 369 (230–532) (b)   Individuals following a “typical 
unrestricted Swedish diet” 
Male/female 
(4/9) 
35–76 1 146 (500–
2 927) (b) Individuals following a vegetarian 
(omitting meat, fish and eggs) or vegan 
(omitting meat, fish, eggs and milk) diet 
Phytate intake was assessed based on food 
consumption data obtained by four-day 
dietary record and the phytate content of 
foods was determined with the method 
described in Harland and Oberleas (1986) 
Plaami and 
Kumpulainen 
(1996) 
Finland nr nr 370   Phytic acid intake was assessed from 
intake of cereal products only 
(consumption data plus the content of 
phytate in cereals) 
Carnovale et al. 
(1987) 
Italy nr nr ISTAT diet: 219  1.54 Phytic acid content of 12 diets collected 
over seven days in a rural area of southern 
Italy; diets were characterised by a high 
content of plant foods. One diet 
representative of national meal pattern 
trends (ISTAT) was also included. Phytic 
acid determined in whole diets according 
to a modification of the colorimetric 
method of Harland and Oberleas (1977) 
High-plant food 
diets: 796 (112–
1 367) (c) 
5.92 (0.90–11.83) (c) 
Torelm and Bruce 
(1982) 
Sweden nr nr 181   Calculated phytic acid intake assessed on 
the basis of selected foods and their 
content of phytic acid 
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Study Country Sex (n) Age (years) Phytic acid/phytate intake (mg/day) Phytate–zinc molar 
ratio median (IQR)
Comments/methods of assessment 
Mean ± SD or 
(range) 
Median (IQR) 
Children 
Amirabdollahian 
and Ash (2010) 
UK Male (298) 1.5–2.5 601 465 (353–733) 11.50 (8.08–17.37) Phytate intake was assessed based on food 
consumption data obtained in the National 
Diet and Nutrition Survey and the content 
of phytate in food according to published 
and unpublished data (the phytate content 
of food in the UK is unavailable) 
Male (300) 2.5–3.5 636 515 (408–718) 12.41 (9.47–16.92) 
Male (250) 3.5–4.5 605 526 (406–725) 11.84 (9.03–15.83) 
Male (184) 4–6 640 576 (435–770) 10.90 (8.99–13.08) 
Male (256) 7–10 733 627 (519–831) 10.61 (9.08–13.50) 
Male (237) 11–14 792 714 (540–929) 10.39 (8.15–13.10) 
Male (179) 15–18 855 780 (616–1 010) 9.34 (7.26–11.79) 
Female (278) 1.5–2.5 615 463 (332–695) 11.90 (8.10–17.18) 
Female (306) 2.5–3.5 577 483 (337–688) 11.90 (8.94–15.78) 
Female (243) 3.5–4.5 566 497 (379–680) 11.58 (9.10–16.27) 
Female (172) 4–6 564 494 (369–657) 10.54 (8.39–13.50) 
Female (225) 7–10 644 566 (461–740) 10.02 (8.42–12.90) 
Female (238) 11–14 657 594 (480–789) 10.60 (8.25–12.76) 
Female (210) 15–18 674 574 (459–829) 10.19 (7.90–13.91) 
IQR, interquartile range; MBIAT, meal-based intake assessment tool; WDR, weighed diet record; nr, not reported; ISTAT, National Institute for Statistics. 
(a): Mean and 95 % confidence interval. 
(b): As reported in Schlemmer et al. (2009), values in the paper by Brune et al. (1989) are for “phytate-phosphorus”. 
(c): Mean (range); mean calculated from individual values given in the paper. 
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Appendix H.  Evaluating data when endogenous faecal zinc was estimated using the zinc 
absorption–intestinal balance method 
In the data used to estimate physiological requirements, the most critical measurements are those of 
EFZ and TAZ. The techniques used to determine EFZ fall into two categories: those that measure EFZ 
directly with the use of isotope tracers administered intravenously and sampled in the faeces 
(Kirchgessner and Weigand isotope dilution, compartmental modelling), and techniques that rely on 
tracer measurements of zinc absorption along with measurements of elemental zinc intestinal balance 
to determine EFZ. The latter techniques have shortcomings and are less reliable than the direct 
measurement methods. 
During compilation and inspection of the individual data, it was observed that several of the studies 
using the absorption–intestinal balance technique had one or more negative EFZ values. As this is 
physiologically impossible, these anomalies were attributed to limitations of the intestinal balance 
technique and the data were removed prior to further analysis. The presence of the negative values 
prompted concern that the accuracy of the remaining data from these studies were also compromised. 
To address this concern, the EFZ data were evaluated in comparison to those acquired with the more 
reliable, and most likely more accurate, direct measurement methods. 
The EFZ and TAZ data from studies using the zinc absorption–intestinal balance method but 
containing no negative EFZ values (Turnlund et al., 1984; Taylor et al., 1991; Knudsen et al., 1996) 
are referred to as the “balance A” data, and the data from studies having negative EFZ values (Wada et 
al., 1985; Hunt J et al., 1992; Hunt et al., 1995; Hunt et al., 1998) are called the “balance B” data in the 
following discussion. They are compared to the data from the “direct” EFZ measurement method 
(Jackson et al., 1984; Sian et al., 1996; Lowe et al., 1997; Miller et al., 2000; King et al., 2001; Pinna 
et al., 2001; Sheng et al., 2009). 
The balance A EFZ and TAZ mean values were not different from the direct means (two-sided t-test 
p-values of 0.60 and 0.95, respectively). While the balance B TAZ means were not different from the 
direct means (p = 0.13), the EFZ means were (p = 0.019). Furthermore, the distribution of the 
combined direct and balance A data (Figure 3) was found to be different from the distribution of the 
balance B data, as assessed with the non-parametric Anderson–Darling test (p = 0.009). 
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Figure 3:  Frequency distributions of endogenous faecal zinc (EFZ) data. The red bars show the 
negative EFZ values, which were removed prior to the analyses described here 
More importantly, the relationships between EFZ and TAZ and EFZ and body weight were different 
for the balance B data. Figure 4 shows that the direct and balance A data exhibited the expected 
positive relationship between EFZ and TAZ and had similar slopes and intercepts. In contrast, there 
was not a corresponding relationship in the balance B data. 
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Figure 4:  Data and regression lines showing the relationships between endogenous faecal zinc 
(EFZ) and total absorbed zinc (TAZ) 
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Figure 5 confirms the positive relationship between EFZ and body weight in the direct data. The 
balance A data suggested a positive relationship, although it was not significant. Again, the balance B 
data showed no evidence of a relationship. 
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Figure 5:  Data and regression lines showing the relationships between endogenous faecal zinc 
(EFZ) and body weight 
Finally, as would be expected from the preceding information, the fitting to the balance B data of the 
model used to estimate the physiological zinc requirement as a function of body weight (Section 5.1.1) 
produces significantly different results. An analysis comparing the model’s fit with both datasets 
demonstrated that the weight and the (TAZ – total endogenous zinc losses) slope parameters were 
significantly different, with p-values of 0.044 and 0.011, respectively. 
Based on the findings that the EFZ data and the balance B studies differed in important ways from the 
direct measurement data, the Panel decided to not include the balance B studies in the estimation of 
physiological zinc requirements. 
Data from Sandstrom et al. (2000) 
The EFZ data from the study of Sandstrom et al. (2000) were generally found to be implausibly high, 
with most values exceeding the range of values observed in the accepted studies (Figure 6). As with 
the studies described above, this is most likely attributable to the use of the zinc absorption–intestinal 
balance method. 
Dietary Reference Values for zinc
 
EFSA Journal 2014;12(10):3844 66
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
0
8
16
24
32
EFZ (mg/d)
fr
eq
ue
nc
y
 
Figure 6:  Frequency distribution of endogenous faecal zinc (EFZ) data from the study of Sandstrom 
et al. (2000) (red) compared with the data from the included studies (black) 
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Appendix I.  Data extracted from the selected studies for estimating physiological zinc requirement of adults 
Study Sex (n) Age 
(years) 
Body 
weight 
mean, 
(range), 
SD (kg) 
Body 
height 
mean, 
(range), 
SD (m) 
Body 
mass 
index 
mean, 
(range), 
SD 
(kg/m2) 
Body 
surface 
area (a) 
mean, 
(range), 
SD (m2) 
EFZ 
method 
EFZ 
mean, 
(range), 
SD 
(mg/day) 
Urine zinc 
mean, 
(range), 
SD 
(mg/day) 
Total 
dietary 
zinc 
mean, 
(range), 
SD 
(mg/day)
Fractional 
absorption 
of zinc 
mean, 
(range), 
SD 
Total 
absorbed 
zinc 
mean, 
(range), 
SD 
(mg/day) 
Total 
dietary 
phytate 
mean, 
(range) 
(mg/day) 
Taylor et al. 
(1991) 
Male (2 × 4) 29–40 66 1.78 21 1.81 Balance (b) 1.6 0.56 3.2 0.69 1.5 NA 
(60–70) (1.7–1.9) (19–22) (1.7–1.9) (0.6–3.4) (0.2–1.4) (0.8–5.6) (0.3–1) (0.8–2.8) 
3.9 0.08 1.1 0.09 1.0 0.40 2.6 0.34 0.74 
Turnlund et al. 
(1984) 
Male (4) 25–32 68 1.74 22 1.82 Balance 2.8 0.53 15 0.34 5.1 0 
(60–81) (1.7–1.8) (21–24) (1.7–2.0) (1.8–4.3) (0.3–1.0) (0.2–0.5) (3.3–7.7) 
9.0 0.06 1.6 0.15 1.1 0.29 0.12 1.9 
Knudsen et al. 
(1996) 
Female (3)/ 
male (5) 
23–27 72 1.81 22 1.90 Balance 3.0 0.43 (c) 10.2 0.29 3.0 660 (NA) 
(60–87) (1.7–1.9) (19–26) (1.7–2.1) (0.5–4.7) (0.3–0.5) (9.4–11) (0.02–0.5) (0.2–5.1) 
9.1 0.09 2.1 0.15 1.4 0.10 0.88 0.12 1.4 
Jackson et al. 
(1984) 
Male (1) 29 80 NA NA NA K&W (d) 3.0 0.63 7.1 0.48 3.4 NA 
Sian et al. 
(1996) 
Female (20) 17–27 53 1.58 21 1.53 K&W 1.8 0.3 (c) 6.6 0.32 2.2 673 (NA) 
(42–65) (1.5–1.7) (18–24) (1.3–1.8) (0.9–3.3) (4.0–8.9) (0.2–0.5) (0.8–3.5) 
6.2 0.06 1.6 0.11 0.70 1.6 0.10 0.92 
Lowe et al. 
(1997) 
Female (6) 21–52 57 1.63 21 1.61 Comp 
model (e) 
1.9 0.21 7.1 0.31 2.1 585 (NA) 
(40–64) (1.5–1.8) (17–24) (1.3–1.8) (1.2–2.6) (0.03–0.4) (5.7–8.8) (0.1–0.6) (1.3–3.2) 
8.7 0.08 2.4 0.16 0.50 0.12 1.1 0.15 0.73 
Sheng et al. 
(2009) 
Female (21) 21–49 64 1.63 24 1.71 K&W 2.7 0.39 11.7 0.30 3.0 835 (250–
2080) (51–97) (1.4–1.8) (18–35) (1.4–2.2) (1.4–5.1) (0.08–0.7) (5.6–29) (0.1–0.5) (1.0–4.7) 
13 0.09 4.2 0.19 0.80 0.18 7.2 0.10 1.1 
Miller et al. 
(2000) 
Female (4)/ 
male (1) 
24–48 67 1.70 23 1.79 Comp 
model 
2.8 0.31 11.5 0.29 3.1 NA 
(47–84) (1.6–1.8) (19–27) (1.4–2.0) (1.5–4.5) (0.06–0.5) (8–20) (0.2–0.4) (2.2–4.4) 
14 0.10 3.3 0.24 1.2 0.17 5.3 0.05 0.86 
King et al. 
(2001) 
Male (5) 21–35 74 1.77 23 1.91 Comp 
model 
2.7 0.46 12.2 0.26 3.2 NA 
(67–93) (1.7–1.8) (21–28) (1.8–2.2) (2.4–3.0) (0.3–0.8) (0.2–0.3) (2.9–3.4) 
11 0.04 3.1 0.15 0.20 0.22 0.02 0.22 
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Study Sex (n) Age 
(years) 
Body 
weight 
mean, 
(range), 
SD (kg) 
Body 
height 
mean, 
(range), 
SD (m) 
Body 
mass 
index 
mean, 
(range), 
SD 
(kg/m2) 
Body 
surface 
area (a) 
mean, 
(range), 
SD (m2) 
EFZ 
method 
EFZ 
mean, 
(range), 
SD 
(mg/day) 
Urine zinc 
mean, 
(range), 
SD 
(mg/day) 
Total 
dietary 
zinc 
mean, 
(range), 
SD 
(mg/day)
Fractional 
absorption 
of zinc 
mean, 
(range), 
SD 
Total 
absorbed 
zinc 
mean, 
(range), 
SD 
(mg/day) 
Total 
dietary 
phytate 
mean, 
(range) 
(mg/day) 
Pinna et al. 
(2001) 
Male (7) 27–47 78 
(71–91) 
1.78 
(1.7–1.9) 
25 
(21–32) 
1.98 
(1.8–2.1) 
Comp 
model 
2.8 
(2.1–4.2) 
0.42 
(0.07–0.7) 
13.7 0.20 
(0.1–0.3) 
2.7 
(1.4–3.6) 
NA 
8 0.08 3.7 0.10 0.81 0.20 0.06 0.82 
Mean (range) 
of males 
Male (31) 30.9 72.7 1.79 23 1.90  2.4 0.54 10.4 0.38 (f) 2.8 NA 
(21–47) (60–93) (1.7–1.9) (19–32) (1.7–2.2) (0.6–4.7) (0.07–1.4) (0.8–20) (0.02–1) (0.2–7.7) 
Mean (range) 
of females  
Female (54) 27.5 59.1 1.62 22 1.64  2.3 0.32 9.0 0.31 2.6 NA 
(17–52) (40–97) (1.4–1.8) (17–35) (1.3–2.2) (0.9–4.5) (0.03–0.71) (4.0–29) (0.1–0.6) (0.8–4.7) 
Where no range or standard deviation is shown, all data had the same value. 
EFZ, endogenous faecal zinc; NA, not available. 
(a): Calculated with Gehan–George equation (Gehan and George, 1970). 
(b): Balance: combination of intestinal balance and “true” absorption measured by zinc stable isotopic labelling of diet. 
(c): Some or all of the data are estimated (see text). 
(d): K&W, measurements using the isotope dilution method of Kirchgessner and Weigand (Kirchgessner et al., 1980; Weigand and Kirchgessner, 1982, 1992). 
(e): Comp model, compartmental modelling. 
(f): For the calculation of an overall mean fractional absorption of zinc (FAZ) for men and women, the FAZ of the zinc-depleted subjects in the study of Taylor et al. (1991) were omitted. The 
overall mean FAZ is 0.30. 
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Appendix J.  Data regression analysis diagnostic results 
The physiological requirement model 
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Figure 7:  Residuals plotted against predictor variables and predicted values of the response variable 
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Figure 8:  Normality plot of residuals 
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The plots of Figures 7 and 8 show no problems with the regression assumptions, although there are 
two points with large standardised and studentised residuals. The externally studentised residuals for 
these data are 3.2 and 3.6. The point with the largest residual is also moderately influential, having a 
Cook’s D-value of 0.51. Nonetheless, all data were retained in the model. 
The normality of the residuals was tested with the D’Agostino–Pearson and Shapiro–Wilk tests. p-
values were 0.020 and 0.051, respectively, but the low p-values were the result of one or two outlying 
points. When the most extreme outlier was removed, the resulting p-values were 0.33 and 0.45, 
respectively, indicating that the remaining data have a normal distribution. 
The homoscedasticity of the residuals was tested with the Breusch–Pagan and Goldfeld–Quandt tests 
giving p-values of 0.74 and 0.99, respectively. Thus, the residuals exhibit constant variance. 
The variance inflation factors were 1.00, indicating no problem with collinearity of variables. 
In addition, there is no evidence that the model is inappropriate. 
The saturation response model 
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Figure 9:  Residuals plotted against predictor variables and predicted values of the response variable 
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Figure 10:  Normality plot of residuals 
The plots of Figures 9 and 10 show no problems with the regression assumptions, although there is a 
hint of decreasing variance with increasing value of TDP. 
The normality of the residuals was tested with the D’Agostino–Pearson and Shapiro–Wilk tests, giving 
p-values of 0.098 and 0.28, respectively, indicating normal distributions. 
As there are no readily available tests for homoscedasticity of residuals in non-linear regression, the 
variance of the residuals was examined by doing linear regression of the absolute values of the 
residuals against the predictor and response variables. p-values from these analyses were ≤ 0.50, 
indicating no problems with non-constant variance. The appearance of larger variance at low TDP 
values is probably the result of the larger number of data at low TDP. 
Again, there is no evidence that the model is inappropriate. 
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Appendix K.  Data extracted from the selected studies for the trivariate saturation response 
model  
Study Total dietary zinc
mean (mg/day) 
Total dietary phytate 
mean (mg/day) 
Total absorbed zinc 
mean (mg/day) 
n Sex 
Hambidge et al. (2004) 8.3 1 370 2.37 6 6M, 4F 
10 3 460 1.51 4 6M, 4F 
10.1 2 700 1.44 4 6M, 4F 
Knudsen et al. (1996) 10.2 660 3.0 8 5M, 3F 
Hunt J et al. (1992) 14 670 3.1 14 14M 
7.8 420 2.3 14 14F 
Hunt et al. (1995) 13 1 045 3.6 14 14F 
6.7 1 045 2 14 14F 
Hunt et al. (1998) 9.1 1 656 2.4 21 21F 
11.1 542 3.7 21 21F 
Wada et al. (1985) 16.4 688 4.1 6 6M 
5.5 688 2.7 6 6M 
Lowe et al. (1997) 7.1 585 2.1 6 6F 
Adams et al. (2002) 4.3 738 1.3 5 2M, 3F 
5 1 820 0.85 5 2M, 3F 
Sian et al. (1996) 5.2 552 1.6 10 10F 
8.1 794 2.8 10 10F 
Pinna (1999) 4.6 254 2.2 7 7M 
Turnlund et al. (1984) 15 0 5.1 4 4M 
15 2 343 2.62 4 4M 
Kristensen et al. (2006) 9.4 845 2.6 16 16F 
9.9 845 2.7 16 16F 
7.5 766 1.8 16 16F 
Kim et al. (2007) 6.87 1 623 1.7 7 7F 
6.87 690 3.2 7 7F 
6.47 1 713 1.5 10 10F 
6.47 760 2.4 10 10F 
Rosado et al. (2009) 3.91 645 1.48 12 12F 
6.56 771 2.03 12 12F 
7.89 2 218 1.56 14 14F 
13.6 2 376 2.08 14 14F 
Sheng et al. (2009) 11.7 835 3.0 21 21F 
Hunt et al. (2008) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.8 326 2.4 8 19M, 20F 
7.4 297 3 8 19M, 20F 
10.9 305 3.9 8 19M, 20F 
15.6 311 4.9 7 19M, 20F 
18.1 285 4.2 8 19M, 20F 
6.2 911 2.4 9 23M, 21F 
9.3 1 726 2.5 9 23M, 21F 
11.9 2 748 2.5 8 23M, 21F 
17.8 3 584 2.8 9 23M, 21F 
21 3 728 3.1 9 23M, 21F 
4.3 292 1.8 8 8F 
6.8 273 2.7 6 6F 
9.4 263 3.5 4 4F 
13.3 265 3.9 4 4F 
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Study Total dietary zinc
mean (mg/day) 
Total dietary phytate 
mean (mg/day) 
Total absorbed zinc 
mean (mg/day) 
n Sex 
Hunt et al. (2008)  
(continued) 
 
 
15.6 246 4.6 4 4F 
4.8 326 3.3 8 19M, 20F 
7.4 297 3.4 8 19M, 20F 
10.9 305 4.1 8 19M, 20F 
15.6 311 5 7 19M, 20F 
18.1 285 4.2 8 19M, 20F 
6.2 911 2.6 9 23M, 21F 
9.3 1 726 2.7 9 23M, 21F 
11.9 2 748 2.7 8 23M, 21F 
17.8 3 584 3 9 23M, 21F 
21 3 728 3.1 9 23M, 21F 
4.3 292 2.6 8 8F 
6.8 273 3.3 6 6F 
9.4 263 4 4 4F 
13.3 265 3.6 4 4F 
15.6 246 5.1 4 4F 
Chung et al. (2008) 11 941 3.91 9 9M 
4 361 2.41 9 9M 
11 941 3.9 9 9M 
4 361 2.73 9 9M 
11 941 3.24 9 9M 
4 361 2.31 9 9M 
Hunt and Beiseigel (2009) 11.5 483 3.8 10 10F 
11.3 1 781 3.0 10 10F 
11.4 391 4.5 10 10F 
12.2 1 789 3.2 10 10F 
M, males; F, females. 
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Appendix L.  Three-dimensional representation of Figure 1 
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ABBREVIATIONS 
Afssa Agence française de sécurité sanitaire des aliments 
AI Adequate Intake 
AR Average Requirement 
BMI body mass index 
COMA Committee on Medical Aspects of Food Policy 
CV coefficient of variation 
D–A–CH Deutschland–Austria–Confoederatio Helvetica 
DH UK Department of Health 
DRV Dietary Reference Value  
EAR Estimated Average Requirement  
EFZ Endogenous faecal zinc 
EU European Union 
EURRECA EURopean micronutrient RECommendations Aligned 
F female 
FAO Food and Agriculture Organization 
FAZ fractional absorption of zinc 
IAEA International Atomic Energy Agency 
IOM US Institute of Medicine of the National Academy of Sciences 
IZiNCG International Zinc Nutrition Consultative Group 
M male 
MRE metal-response element 
MTF MRE-binding transcription factor 
NNR Nordic Nutrition Recommendations 
PRI Population Reference Intake 
RDA Recommended Dietary Allowance 
REE resting energy expenditure 
RNI Reference Nutrient Intake 
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SCF Scientific Committee for Food 
TAZ total absorbed zinc 
TDP total dietary phytate 
TDZ total dietary zinc 
UNICEF United Nations Children’s Fund 
UL Tolerable Upper Intake Level 
WHO World Health Organization 
 
